<SEC-DOCUMENT>0001104659-19-055983.txt : 20191024
<SEC-HEADER>0001104659-19-055983.hdr.sgml : 20191024
<ACCEPTANCE-DATETIME>20191024073330
ACCESSION NUMBER:		0001104659-19-055983
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		22
CONFORMED PERIOD OF REPORT:	20191023
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20191024
DATE AS OF CHANGE:		20191024

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IDEXX LABORATORIES INC /DE
		CENTRAL INDEX KEY:			0000874716
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				010393723
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19271
		FILM NUMBER:		191164831

	BUSINESS ADDRESS:	
		STREET 1:		ONE IDEXX DRIVE
		CITY:			WESTBROOK
		STATE:			ME
		ZIP:			04092-2041
		BUSINESS PHONE:		2075560300

	MAIL ADDRESS:	
		STREET 1:		ONE IDEXX DRIVE
		CITY:			WESTBROOK
		STATE:			ME
		ZIP:			04092-2041

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	IDEXX CORP / DE
		DATE OF NAME CHANGE:	19600201
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm19207851_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:us-roles="http://fasb.org/us-roles/2019-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:idxx="http://idexx.com/20191023">
<head>
     <title></title>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_021_US%2DGAAP%2D2019 -->
<!-- Field: Set; Name: xdx; ID: xdx_03D_idxx_idexx.com_20191023 -->
<!-- Field: Set; Name: xdx; ID: xdx_047_20191022_20191023 -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DEntityCentralIndexKey_0000874716 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_052_edei%2D%2DEntityRegistrantName_IDEXX LABORATORIES INC /DE -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
  <ix:hidden>
    <ix:nonNumeric contextRef="From2019-10-22to2019-10-23" name="dei:EntityCentralIndexKey">0000874716</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2019-10-22to2019-10-23" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2019-10-22to2019-10-23" name="dei:EntityRegistrantName">IDEXX LABORATORIES INC /DE</ix:nonNumeric>
    </ix:hidden>
  <ix:references>
    <link:schemaRef xlink:href="idxx-20191023.xsd" xlink:type="simple" />
    </ix:references>
  <ix:resources>
    <xbrli:context id="From2019-10-22to2019-10-23">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000874716</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-10-22</xbrli:startDate>
        <xbrli:endDate>2019-10-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    </ix:resources>
  </ix:header>
</div>


<p style="margin: 0; font-family: Arial, Helvetica, Sans-Serif"></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Arial, Helvetica, Sans-Serif"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>FORM
<span id="xdx_90F_edei--DocumentType_c20191022__20191023_zTzsuzqF8qx6"><ix:nonNumeric contextRef="From2019-10-22to2019-10-23" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Date
of Report (Date of earliest event reported): <b><span id="xdx_909_edei--DocumentPeriodEndDate_c20191022__20191023_z6pHBEpRRWfb"><ix:nonNumeric contextRef="From2019-10-22to2019-10-23" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">October 23, 2019</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;<img src="tm1920785-1_8kimg01.jpg" alt="" /></span></p>

<p style="font: 18pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>IDEXX
LABORATORIES, INC.</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">(Exact
name of registrant as specified in charter)</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; text-align: left; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
<tr style="vertical-align: bottom; font-family: Arial, Helvetica, Sans-Serif">
    <td style="text-align: center; width: 32%; font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_902_edei--EntityIncorporationStateCountryCode_c20191022__20191023_zkGymaQ1GKw7"><ix:nonNumeric contextRef="From2019-10-22to2019-10-23" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="text-align: center; width: 32%; font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90A_edei--EntityFileNumber_c20191022__20191023_zqxZY1YAfpkc"><ix:nonNumeric contextRef="From2019-10-22to2019-10-23" name="dei:EntityFileNumber">000-19271</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="text-align: center; width: 32%; font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_902_edei--EntityTaxIdentificationNumber_c20191022__20191023_zzTa07Yjyrv5"><ix:nonNumeric contextRef="From2019-10-22to2019-10-23" name="dei:EntityTaxIdentificationNumber">01-0393723</ix:nonNumeric></span></b></span></td></tr>
<tr style="vertical-align: bottom; font-family: Arial, Helvetica, Sans-Serif">
    <td style="text-align: center; font-family: Arial, Helvetica, Sans-Serif"><span style="font: 10pt Times New Roman, Times, Serif">(State
    or Other Jurisdiction</span></td>
    <td>&#160;</td>
    <td style="text-align: center; font-family: Arial, Helvetica, Sans-Serif"><span style="font: 10pt Times New Roman, Times, Serif">(Commission
    File Number)</span></td>
    <td>&#160;</td>
    <td style="text-align: center; font-family: Arial, Helvetica, Sans-Serif"><span style="font: 10pt Times New Roman, Times, Serif">(I.R.S.
    Employer Identification No.)</span></td></tr>
<tr style="vertical-align: bottom; font-family: Arial, Helvetica, Sans-Serif">
    <td style="text-align: center; font-family: Arial, Helvetica, Sans-Serif"><span style="font: 10pt Times New Roman, Times, Serif">of
    Incorporation)</span></td>
    <td>&#160;</td>
    <td style="text-align: center; font-family: Arial, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td>&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; text-align: left; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
<tr style="vertical-align: bottom; font-family: Arial, Helvetica, Sans-Serif">
    <td style="text-align: center; width: 32%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90C_edei--EntityAddressAddressLine1_c20191022__20191023_zJtykMM0SLhj"><ix:nonNumeric contextRef="From2019-10-22to2019-10-23" name="dei:EntityAddressAddressLine1">One IDEXX Drive</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressCityOrTown_c20191022__20191023_zFpp8Kj9QmO3"><ix:nonNumeric contextRef="From2019-10-22to2019-10-23" name="dei:EntityAddressCityOrTown">Westbrook</ix:nonNumeric></span>, <span id="xdx_90E_edei--EntityAddressStateOrProvince_c20191022__20191023_zExMqh45m6jg"><ix:nonNumeric contextRef="From2019-10-22to2019-10-23" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Maine</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 32%; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 2%">&#160;</td>
    <td style="text-align: center; width: 32%; font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_906_edei--EntityAddressPostalZipCode_c20191022__20191023_zq0sXSzX4rp1"><ix:nonNumeric contextRef="From2019-10-22to2019-10-23" name="dei:EntityAddressPostalZipCode">04092</ix:nonNumeric></span></b></span></td></tr>
<tr style="font-family: Arial, Helvetica, Sans-Serif">
    <td style="vertical-align: top; font-family: Arial, Helvetica, Sans-Serif"><p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center; font-family: Arial, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif">(Address
                                         of Principal Executive Offices)</span></p></td>
    <td><i>&#160;</i></td>
    <td style="vertical-align: bottom; font-family: Arial, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></td>
    <td><i>&#160;</i></td>
    <td style="vertical-align: top; text-align: center; font-family: Arial, Helvetica, Sans-Serif"><span style="font: 10pt Times New Roman, Times, Serif">(Zip
    Code)</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_90D_edei--CityAreaCode_c20191022__20191023_z8aQPBVPScv8" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2019-10-22to2019-10-23" name="dei:CityAreaCode"><b>207</b></ix:nonNumeric></span><b><span style="font-family: Times New Roman, Times, Serif">.<span id="xdx_904_edei--LocalPhoneNumber_c20191022__20191023_zDLlJUI2b9eh"><ix:nonNumeric contextRef="From2019-10-22to2019-10-23" name="dei:LocalPhoneNumber">556.0300</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">(Registrant's
telephone number, including area code)</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>Not
Applicable</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">(Former
name or former address, if changed since last report)</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions: </span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; text-align: left; font: 10pt Arial, Helvetica, Sans-Serif; margin-right: auto; margin-left: auto; border-collapse: collapse">
<tr style="vertical-align: bottom; font-family: Arial, Helvetica, Sans-Serif">
    <td style="padding: 2px; text-align: left; width: 3%; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_903_edei--WrittenCommunications_c20191022__20191023_z87PLzPHunN1"><ix:nonNumeric contextRef="From2019-10-22to2019-10-23" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="padding: 2px; text-align: justify; width: 97%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: 10pt Times New Roman, Times, Serif">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="text-indent: 0px; margin-top: 0pt; margin-bottom: 0pt; font-family: Arial, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; text-align: left; font: 10pt Arial, Helvetica, Sans-Serif; margin-right: auto; margin-left: auto; border-collapse: collapse">
<tr style="vertical-align: bottom; font-family: Arial, Helvetica, Sans-Serif">
    <td style="padding: 2px; text-align: left; width: 3%; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_903_edei--SolicitingMaterial_c20191022__20191023_zWJvzTapEQle"><ix:nonNumeric contextRef="From2019-10-22to2019-10-23" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="padding: 2px; text-align: justify; width: 97%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: 10pt Times New Roman, Times, Serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; text-align: left; font: 10pt Arial, Helvetica, Sans-Serif; margin-right: auto; margin-left: auto; border-collapse: collapse">
<tr style="font-family: Arial, Helvetica, Sans-Serif">
    <td style="padding: 2px; vertical-align: top; text-align: left; width: 3%; font-family: Arial, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_905_edei--PreCommencementTenderOffer_c20191022__20191023_z9X6sVtaoCu3"><ix:nonNumeric contextRef="From2019-10-22to2019-10-23" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="padding: 2px; vertical-align: top; text-align: left; width: 97%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; text-align: left; font: 10pt Arial, Helvetica, Sans-Serif; margin-right: auto; margin-left: auto; border-collapse: collapse">
<tr style="font-family: Arial, Helvetica, Sans-Serif">
    <td style="padding: 2px; vertical-align: top; text-align: left; width: 3%; font-family: Arial, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_90D_edei--PreCommencementIssuerTenderOffer_c20191022__20191023_z9CBwvpuwhq8"><ix:nonNumeric contextRef="From2019-10-22to2019-10-23" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="padding: 2px; vertical-align: top; text-align: left; width: 97%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; text-align: left; font: 10pt Arial, Helvetica, Sans-Serif; margin-right: auto; margin-left: auto; border-collapse: collapse">
<tr style="vertical-align: bottom; font-family: Arial, Helvetica, Sans-Serif">
    <td style="padding: 2px; text-align: center; width: 33%; font-family: Arial, Helvetica, Sans-Serif; border-bottom: Black 1pt solid; vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif">Title
    of each class</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 2px; text-align: center; width: 32%; font-family: Arial, Helvetica, Sans-Serif; border-bottom: Black 1pt solid; vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif">Trading
    Symbol(s)</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 2px; text-align: center; width: 33%; font-family: Arial, Helvetica, Sans-Serif; border-bottom: Black 1pt solid; vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif">Name
    of each exchange on which<br />
    registered</span></td></tr>
<tr style="vertical-align: bottom; font-family: Arial, Helvetica, Sans-Serif">
    <td style="padding: 2px; text-align: center; font-family: Arial, Helvetica, Sans-Serif; vertical-align: top"><span id="xdx_900_edei--Security12bTitle_c20191022__20191023_z1pziRk8nNC9" style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2019-10-22to2019-10-23" name="dei:Security12bTitle">Common
    Stock, $0.10 par value per share</ix:nonNumeric></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 2px; text-align: center; font-family: Arial, Helvetica, Sans-Serif; vertical-align: top"><span id="xdx_909_edei--TradingSymbol_c20191022__20191023_zGuBdAxO5Nc4" style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2019-10-22to2019-10-23" name="dei:TradingSymbol">IDXX</ix:nonNumeric></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 2px; text-align: center; font-family: Arial, Helvetica, Sans-Serif; vertical-align: top"><span id="xdx_907_edei--SecurityExchangeName_c20191022__20191023_zMbpLojv2xEl" style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2019-10-22to2019-10-23" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ
    Global Select Market</ix:nonNumeric></span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Emerging
growth company</span>&#160;<span style="font-family: Wingdings"><span id="xdx_90A_edei--EntityEmergingGrowthCompany_c20191022__20191023_zAQrI23UXdw5"><ix:nonNumeric contextRef="From2019-10-22to2019-10-23" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span>&#160;<span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid">&#160;</div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>Item 5.02</b></td><td style="text-align: justify"><b>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Recent Actions</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On October 23, 2019,
IDEXX Laboratories, Inc. (the &#8220;<span style="text-decoration: underline">Company</span>&#8221;) and Jonathan W. Ayers, the Company&#8217;s Chairman of the Board and
former President and Chief Executive Officer, mutually agreed that Mr. Ayers, who has been on medical leave since June 28, 2019,
will cease to be employed by the Company as of November 1, 2019 (the &#8220;<span style="text-decoration: underline">Transition Date</span>&#8221;) and transition to the
role of external Senior Advisor to the Company. Mr. Ayers will continue to serve as a member of the Company&#8217;s Board of Directors
(the &#8220;<span style="text-decoration: underline">Board</span>&#8221;) but will no longer serve as its Chairman. In connection with the foregoing, on October 23, 2019,
Mr. Ayers and the Company entered into a Mutual Separation Agreement (the &#8220;<span style="text-decoration: underline">Mutual Separation Agreement</span>&#8221;) and
a Senior Advisory Agreement (the &#8220;<span style="text-decoration: underline">Senior Advisory Agreement</span>&#8221;), as more fully described below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Also, on October 23,
2019, the Board appointed Jonathan (Jay) Mazelsky as the President and Chief Executive Officer of the Company, effective
as of October 23, 2019. Mr. Mazelsky has been serving as the Interim President and Chief Executive Officer of the Company since
June 28, 2019, as was previously disclosed in the Company&#8217;s current report on Form 8-K filed on July 1, 2019. In connection
with the foregoing, on October 23, 2019, Mr. Mazelsky and the Company entered into the Second Amended and Restated Executive Employment
Agreement to reflect his new arrangement (the &#8220;<span style="text-decoration: underline">Mazelsky Employment Agreement</span>&#8221;), as more fully described below.
In connection with his promotion to serve as the President and Chief Executive Officer, Mr. Mazelsky was also elected to the Board,
effective as of October 23, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In light of these changes,
also on October 23, 2019, the Board elected Lawrence D. Kingsley to serve as the Board&#8217;s Independent Non-Executive Chairman,
effective as of November 1, 2019. Mr. Kingsley has been a member of the Board since October 2016 and served as its Independent
Lead Director since May 2018.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are no related
person transactions (or proposed related person transactions) with respect to Mr. Mazelsky reportable under Item 5.02(d) of Form
8-K and Item 404(a) of Regulation S-K since the beginning of the Company&#8217;s last fiscal year. Mr. Mazelsky will not receive
any compensation in connection with his service on the Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Mutual Separation Agreement with
Jonathan Ayers </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the
Mutual Separation Agreement and consistent with his rights under his employment agreement with the Company, dated January 22,
2002, Mr. Ayers will receive: (i) two years&#8217; base salary continuation, equal to approximately $1.6 million payable
ratably over a two-year period, and (ii) a lump sum payment equal to $40,000 to compensate Mr. Ayers for approximately 24
months of medical insurance coverage premium costs. In addition, Mr. Ayers will receive a lump sum payment equal to $833,333,
representing a pro-rated annual target bonus for 2019 through the Transition Date. Mr. Ayers&#8217;s unvested stock options
will continue to vest in accordance with the schedule set forth in the applicable award agreement without any continued
service requirement and all of his outstanding stock options, including those vested as of the Transition Date and those that
will become vested thereafter, will remain exercisable without any continued service requirement until the expiration date
set forth in each stock option award agreement. As a result of his severance payments and the modification of Mr.
Ayers&#8217;s outstanding stock options, the Company will recognize a charge of approximately $13 million in the fourth
quarter of 2019, representing the cost of the severance and an acceleration of the cost of the equity awards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. Ayers&#8217;s aforementioned
entitlements under the Mutual Separation Agreement are subject to his execution and delivery, without revocation, of a general
release of any claims, and are contingent on his execution, delivery and compliance with a non-disclosure agreement and a non-competition
agreement, providing for non-competition and non-solicitation restrictions for a period until the later of (i) two years following
the end of Mr. Ayer&#8217;s senior advisory services (as described below) and Board service, and (ii) the date on which all of
Mr. Ayers&#8217;s outstanding stock options have fully vested.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. Ayers will also,
as of immediately following the Transition Date, be entitled to receive payment for his service as a non-employee director of the
Company pursuant to the Company&#8217;s compensation policy for non-employee directors in effect from time to time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Mutual Separation
Agreement, the terms of which are incorporated herein by reference, is attached hereto as Exhibit 10.1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Senior Advisory Agreement with Jonathan
Ayers </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As noted above, Mr.
Ayers will serve as a Senior Advisor to the Company pursuant to the Senior Advisory Agreement, effective as of November 2, 2019.
Under this arrangement, Mr. Ayers will provide advice and services related to such matters as identified from time to time and
agreed to by Mr. Ayers and the President and Chief Executive Officer of the Company, and will receive compensation in the form
of advisory fees at a rate of $240,000 per year (the &#8220;<span style="text-decoration: underline">Advisory Fees</span>&#8221;), generally payable in arrears in four
installments of $60,000 on each of February 1, May 1, August 1, and November 1. The Senior Advisory Agreement does not provide
for a specific term and may be terminated by either party by providing 90 days&#8217; written notice to the other party. In the
event that the term of the Senior Advisory Agreement ends in between any of the aforementioned payment dates, Mr. Ayers shall receive
a pro-rated portion of the applicable Advisory Fees for the period prior to termination of the Senior Advisory Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Senior Advisory
Agreement, the terms of which are incorporated herein by reference, is attached hereto as Exhibit 10.2.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Mazelsky Employment Agreement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Mazelsky Employment
Agreement, appointing him President and Chief Executive Officer, and making him eligible to be a member of the Board, generally
provides for: (i) an annual base salary of $850,000, which will be reviewed by the Board on an annual basis commencing in the first
quarter of 2021, (ii) an annual bonus opportunity with a target, beginning on the effective date of the Mazelsky Employment Agreement,
equal to 125% of Mr. Mazelsky&#8217;s base salary, (iii) an equity grant of stock options to purchase shares of Company common
stock to be granted on November 4, 2019, with a grant date fair value of approximately $2,000,000, an exercise price equal to 110%
of the fair market value of a share of the Company&#8217;s common stock on the date of grant, and a ten-year term and vesting ratably
over five years (so long as Mr. Mazelsky remains employed by the Company or as otherwise provided in the Mazelsky Employment Agreement),
and (iv) in February 2020, subject to approval of the Compensation Committee of the Board (the &#8220;Compensation Committee&#8221;),
an additional grant, with a grant date fair value of approximately $4,000,000, in the form and with those terms and conditions
as determined by the Compensation Committee consistent with awards to the Company&#8217;s other executive officers in February
2020, unless otherwise determined by the Compensation Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the terms of
the Mazelsky Employment Agreement, if Mr. Mazelsky is terminated by the Company without Cause (as such term is defined therein)
other than during a Change of Control Period (as defined below), subject to Mr. Mazelsky&#8217;s ongoing compliance with applicable
restrictive covenant agreements and his execution, without revocation, of a general release of claims, Mr. Mazelsky will be entitled
to the following: (i) base salary continuation for two years following his termination date (the &#8220;<span style="text-decoration: underline">Severance Period</span>&#8221;),
(ii) a lump sum cash payment in an amount equivalent to two years of the employer portion of medical coverage for Mr. Mazelsky
and his dependents to the same extent as was paid immediately prior to the termination of employment, and (iii) continued vesting
of any outstanding equity incentive awards that otherwise would have vested during the Severance Period, which awards, if stock
options, will remain exercisable for 90 days following the end of the Severance Period. In addition, any options that were vested
immediately prior to Mr. Mazelsky&#8217;s termination date will have an exercise period of (x) 90 days following his termination
or (y) if Mr. Mazelsky is &#8220;Retirement-eligible&#8221; (as defined in the applicable equity award agreement) as of the termination
date, an exercise period of 24 months following the termination date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If such termination
by the Company without Cause occurs, or if Mr. Mazelsky resigns for Good Reason, each within 24 months following a Change of Control
(as defined therein) (the &#8220;<span style="text-decoration: underline">Change of Control Period</span>&#8221;), Mr. Mazelsky will be entitled to: (i) a lump sum payment
equal to three times the sum of (x) his base salary and (y) generally, the average of annual bonus amounts paid in the immediately
prior three years, (ii) a lump sum payment in an amount equivalent to three years of the Company&#8217;s payment of the employer
portion of medical coverage for Mr. Mazelsky and his dependents to the same extent as was paid immediately prior to the termination
of employment, (iii) full vesting of any unvested equity awards outstanding as of the termination date, and (iv) reimbursement
for outplacement services and relocation costs up to $12,500 each year until the earlier of two years following the termination
date or when Mr. Mazelsky secures full time employment. Consistent with the terms of the Amended and Restated Employment Agreement,
dated May 26, 2013, by and between Mr. Mazelsky and the Company which provides certain rights for Mr. Mazelsky upon a change of
control of the Company (the &#8220;<span style="text-decoration: underline">Existing Change of Control Agreement</span>&#8221;), and the terms of the applicable Company
stock incentive plans, 25% of Mr. Mazelsky&#8217;s outstanding unvested equity awards will automatically vest upon a change of
control of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Together with executing
the Mazelsky Employment Agreement, Mr. Mazelsky also entered into a non-disclosure agreement and a non-competition agreement, providing
for non-competition and non-solicitation restrictions effective while Mr. Mazelsky is an employee of the Company and for a period
of two years following a termination of employment for any reason.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Mazelsky Employment
Agreement, the terms of which are incorporated herein by reference, is attached hereto as Exhibit 10.3. The Mazelsky Employment
Agreement supersedes the Existing Change of Control Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>Item 7.01</b></td><td style="text-align: justify"><b>Regulation FD Disclosure.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A copy of the Company&#8217;s press release
dated October 24, 2019 announcing these matters is furnished as Exhibit 99.1 to this Form 8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item&#160;9.01 &#8212; Financial Statements and Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 4%; font-size: 10pt"><span style="font-size: 10pt">(d)</span></td>
    <td style="font-size: 10pt"><span style="font-size: 10pt">Exhibits: </span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 12%; border-bottom: black 1pt solid"><span style="font-size: 10pt"><b>Exhibit&#160;Number</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="width: 86%; border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td><a href="tm19207851_ex10-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">10.1</span></a></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="tm19207851_ex10-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Mutual Separation Agreement, dated October 23, 2019, by and between IDEXX Laboratories Inc. and Mr. Jonathan W. Ayers</span></a></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td><a href="tm19207851_ex10-2.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">10.2</span></a></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="tm19207851_ex10-2.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Senior Advisory Agreement, dated October 23, 2019, by and between IDEXX Laboratories Inc. and Mr. Jonathan W. Ayers</span></a></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td><a href="tm19207851_ex10-3.htm"><span style="font-size: 10pt">10.3</span></a></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="tm19207851_ex10-3.htm"><span style="font-size: 10pt">Second Amended and Restated Employment Agreement, dated October 23, 2019, by and between IDEXX Laboratories Inc. and Jonathan (Jay) Mazelsky</span></a></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td><a href="tm19207851_ex99-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">99.1</span></a></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="tm19207851_ex99-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Press Release entitled &#8220;IDEXX Laboratories Announces Leadership Changes,&#8221; issued by the Company on October 24, 2019.</span></a></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 0; text-align: center">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left">IDEXX LABORATORIES, INC.</td></tr>
<tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 50%; font: 10pt Times New Roman, Times, Serif">Date: October 24, 2019</td>
    <td style="width: 4%; font: 10pt Times New Roman, Times, Serif; text-align: left">By:</td>
    <td style="width: 46%; font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid">/s/ Sharon E. Underberg</td></tr>
<tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Name:&#160;&#160;Sharon E. Underberg</td></tr>
<tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Title:  &#160;&#160;&#160;Corporate Vice President, General Counsel and Secretary</td></tr>
</table>




<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>


</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjV0KwjAQhE/QOyx5LppaROybFi1iFSkivsZ2lWCbLZv4dyRvaWwRl4VlmflmhAhFRktdI8NxXuSwx6atlUMo8IyMpkTvSFfrBPwt8KKtY2Vc9/7AlDyDnhkP5Kn0Qme9a4tVAnIyjOUwmoKMkjiG2UYEXz0lc9YVGqdVDcpUsGNqWaNT/OoT9upJhppXV3VAtppMAtFA9vIbRjIawZbu6kF8tZDnqQjCbgKRMd3ab83NOmpgUWPju2yP/jf4ADFvSWw= -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>tm19207851_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right">Execution Copy</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">October 23, 2019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Jonathan W. Ayers</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Re: Mutual Separation Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Jon:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This letter agreement (this &ldquo;<U>Mutual
Separation Agreement</U>&rdquo;) and a separate senior advisor agreement being entered into by you and IDEXX Laboratories, Inc.
(the &ldquo;<U>Company</U>&rdquo;) simultaneously herewith (the &ldquo;<U>Senior Advisory Agreement</U>&rdquo;) set forth the terms
under which your tenure as an employee of the Company and its subsidiaries and affiliates (hereinafter collectively referred to
as &ldquo;<U>IDEXX</U>&rdquo;) will end and you will (i) continue to serve the Company as a member of the Board of Directors (&ldquo;<U>Board</U>&rdquo;)
but will resign as Chairman of the Board, and (ii) begin serving the Company as a non-employee senior advisor (a &ldquo;<U>Senior
Advisor</U>&rdquo;). By signing below you agree to the terms and conditions set forth in this Mutual Separation Agreement, and
agree and acknowledge the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">1.</TD><TD><U>Transition</U>. Your tenure as an employee of IDEXX will end effective on November 1, 2019 (the &ldquo;<U>Transition Date</U>&rdquo;).
You acknowledge and agree that, as of the Transition Date, you shall be deemed to have resigned from all positions you hold as
an officer of IDEXX, as an officer or director of any subsidiary or affiliate of the Company, and as Chairman of the Board of Directors
of the Company, and you agree that you will cooperate with IDEXX to execute in a timely manner any additional documentation that
may be required to effect your resignation from such positions. For the avoidance of doubt, the resignations contemplated herein
do not include resignation from service as a director of the Company.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">2.</TD><TD><U>Transition Payment</U>. Your usual pay will continue until and cease on the Transition Date. Subject to your execution of
this Mutual Separation Agreement and conditioned on the Release (as defined herein) becoming effective and irrevocable as set forth
in Paragraph 2.e. and the other terms and conditions hereof, following the Transition Date, the Company will pay you:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">a.</TD><TD>Two years of your base salary (at your base salary rate in effect immediately prior to the Transition Date as separation pay).
This amount, equaling $1,600,000.00, shall be paid to you in substantially equal installments in accordance with the Company&rsquo;s
standard payroll practices (subject to applicable tax withholding obligations), beginning on the first payroll date coincident
with or next following the one month anniversary of the Transition Date, subject to the terms of Paragraphs 2.d and 2.e hereof.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">b.</TD><TD>An amount equal to $40,000.00 (estimated to equal approximately 18 months of COBRA premium costs plus 6 additional months of
health coverage premium costs), which shall be paid in a lump sum (less applicable withholdings) on the first payroll date coincident
with or next following the Transition Date, subject to the terms of Paragraphs 2.d and 2.e hereof.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">c.</TD><TD>An amount equal to $833,333.00, which shall be paid to you in a lump sum (less applicable tax withholding obligation) on the
first payroll date coincident with or next following the Transition Date, subject to the terms of Paragraph 2.e hereof.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">d.</TD><TD>Notwithstanding anything in this Mutual Separation Agreement to the contrary, because you have been determined to be a &ldquo;specified
employee&rdquo; within the meaning of Section 409A (as defined below), payment of the amounts due under Paragraphs 2.a and 2.b
herein shall commence on the first payroll date coincident with or next following the six-month anniversary of the Transition Date
(the &ldquo;<U>Six-Month Delay Period</U>&rdquo;); provided that each monthly payment that would have otherwise been due to you
under Paragraphs 2.a and 2.b during the Six Month Delay Period shall be paid to you (without interest) as part of the first payment
made to you in accordance with this Paragraph 2.d.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">e.</TD><TD>You acknowledge and agree that the payments set forth in this Paragraph 2 (collectively, the &ldquo;<U>Transition Payments</U>&rdquo;)
shall be in lieu of severance payments or other consideration, if any, you may be entitled to under any other agreement or arrangement
with IDEXX or under any IDEXX policy or plan, including, but not limited to the Employment Agreement, dated January 22, 2002, between
you and the Company (the &ldquo;<U>Employment Agreement</U>&rdquo;), the IDEXX Laboratories, Inc. Severance Benefit Plan, as initially
adopted effective January 1, 1998, including any amendments thereto (the &ldquo;<U>Severance Plan</U>&rdquo;) and the Amended and
Restated Executive Employment Agreement, dated February 13, 2011, between you and the Company (the &ldquo;<U>COC Agreement</U>&rdquo;).
You further acknowledge and agree that the Transition Payments and the additional vesting and exercisability of your <U>Outstanding
Stock Options</U> (as defined below) provided for under Paragraph 3 below (the &ldquo;<U>Additional Option Vesting/Exercisability</U>,&rdquo;
and together with the Transition Payments, the &ldquo;<U>Agreement Consideration</U>&rdquo;) provide valuable and adequate consideration
for (x) your release of any claims under the Age Discrimination in Employment of 1967, as amended, and the release of all other
claims and the covenant not to sue as set forth in the Release (as defined herein) and (y) your execution and delivery, your agreement
to be bound by, and your continued compliance with, the terms of the <FONT STYLE="color: #1B1B1B">Invention and Non-Disclosure
Agreement </FONT>attached hereto as Exhibits A and the Non-Compete Agreement attached hereto as Exhibit B (such agreements to be
referred to herein as the &ldquo;<U>Ancillary Agreements</U>&rdquo;). Further, as set forth above, IDEXX&rsquo;s obligation to
provide the Transition Payments and the Additional Option Vesting/Exercisability are conditioned on (i) your executing and delivering
to IDEXX, and continued compliance with, the Ancillary Agreements simultaneously with this Mutual Separation Agreement, which shall
be effective immediately upon your execution and delivery thereof, and (ii) your executing and delivering to the Company a general
release of claims substantially in the form attached hereto as Exhibit C (the &ldquo;<U>Release</U>&rdquo;) by November 13, 2019,
and such Release becoming effective and irrevocable under its terms.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">f.</TD><TD>Subject to the terms for each as described above, the payments set forth in Paragraphs 2.a., 2.b., and 2.c. shall be paid to
you through the direct deposit system, if you have direct deposit established. If you do not have direct deposit, payments will
be mailed to you at the address the Company has for you on file.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">3.</TD><TD><U>Stock Options </U>. You acknowledge and agree, that in further consideration of your execution and delivery of an irrevocable
Release as set forth in Paragraph 2.e. and your execution and delivery (and agreement to be bound by the terms) of the Ancillary
Agreements, with respect to each of the outstanding annual stock option awards previously granted to you (each, an &ldquo;<U>Outstanding
Stock Option</U>&rdquo;), notwithstanding anything to the contrary in any document or agreement, whether or not you continue to
serve as a director of the Company or as Senior Advisor, (i) the Outstanding Stock Options that are unvested as of the Transition
Date (&ldquo;<U>Unvested Outstanding Stock Options</U>&rdquo;) will continue to vest in accordance with the vesting schedule set
forth in the applicable Outstanding Stock Option award agreement; and (ii) each Outstanding Stock Option that is unexercised as
of the Transition Date shall be exercisable by you (with respect to Unvested Outstanding Stock Options, only after the vesting
thereof) until the expiration date of the Outstanding Stock Option as set forth in the applicable Outstanding Stock Option award
agreement. Any Outstanding Stock Option not exercised prior to such Outstanding Stock Option&rsquo;s expiration date shall be forfeited.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">4.</TD><TD><U>IDEXX Executive Deferred Compensation Plan</U>. Effective on the Transition Date you will have incurred a &ldquo;Separation
From Service&rdquo; under the terms of the IDEXX Executive Deferred Compensation Plan (the &ldquo;<U>Deferred Compensation Plan</U>&rdquo;)
and will become eligible for a distribution of your account therein in accordance with the terms of the Deferred Compensation Plan,
the applicable deferral elections you have previously made and Section 409A (as defined below).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">5.</TD><TD><U>IDEXX Retirement and Incentive Savings Plan (401(k) Plan)</U>. If you are a participant in the IDEXX Retirement and Incentive
Savings Plan (401(k) Plan), effective on the Transition Date you will become an inactive participant in such plan and will become
eligible for a distribution from such plan. As a result, from and after the Transition Date, you may, for example, roll over your
account to an IRA or to another qualified employer 401(k) plan.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">6.</TD><TD><U>Health, Dental, and Vision Plans for Employees of IDEXX</U>. If applicable, your enrollment in the IDEXX medical, dental,
and vision plans will continue through the last day of the calendar month in which the Transition Date occurs. After that date,
to the extent you are eligible, you may continue your medical and dental coverage for eighteen months under the provisions of the
Consolidated Omnibus Budget Reconciliation Act of 1985 (&ldquo;COBRA&rdquo;) by paying the total cost of the premium plus an additional
2% administrative charge as provided by COBRA (details will be provided to you separately). As noted in Paragraph 2.b. hereof,
subject to your otherwise complying with the terms of this Mutual Separation Agreement, including Paragraph 2.e. hereof, the Company
will pay you in a lump sum payment an amount equal to approximately 18 months of COBRA premium costs plus six months of a substantially
similar monthly amount, which you may, but are not required, to put toward obtaining supplemental medical coverage following the
expiration of the COBRA continuation period in accordance with law. Notwithstanding the foregoing, if the Company&rsquo;s making
this lump sum payment to you under this Mutual Separation Agreement would violate the nondiscrimination rules applicable to health
plans or self-insured plans under Section 105(h) of the Internal Revenue Code of 1986, as amended (the &ldquo;<U>Code</U>&rdquo;),
or result in the imposition of penalties under the Patient Protection and Affordable Care Act of 2010 and the related regulations
and guidance promulgated thereunder (the &ldquo;<U>PPACA</U>&rdquo;), the parties agree to reform this Mutual Separation Agreement
in a manner as is necessary to comply with the PPACA and the Code. Further, nothing herein provided shall be construed to extend
the period of time over which COBRA continuation coverage otherwise may be provided to you and/or your dependents.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">7.</TD><TD><U>Basic Life Insurance, Basic Accidental Death &amp; Dismemberment Coverage, and Disability Coverage</U>. Your basic life
insurance coverage terminates effective as of the Transition Date. This coverage may be converted to an individual policy (details
will be provided to you separately). Your basic accidental death and dismemberment coverage terminates effective as of the Transition
Date. This coverage may not be converted to an individual policy.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Your long- and short-term disability coverage terminates
effective as of the Transition Date. Your eligibility for disability benefits relating to occurrences on or prior to the Transition
Date will not be affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">8.</TD><TD><U>Paid Time Off (PTO) Pay</U>. You acknowledge and agree that during the period of paid medical leave since June 28, 2019,
all of your accrued PTO time has been deemed to have been fully utilized, and as a result you will not receive any payment for
accrued PTO in connection with your Transition Date.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">9.</TD><TD><U>Expense Reports and Company Credit Cards</U>. You must submit any outstanding expense reports for your time as an employee
of IDEXX no later than the Transition Date. Your IDEXX credit cards will be canceled on the Transition Date. IDEXX may pay any
credit card balances not covered by valid expense reports received after the Transition Date and deduct the amount of such payments
from amounts that are provided in Paragraph 2 of this Mutual Separation Agreement. Without limiting the foregoing, you agree that
the Company may withhold from any Transition Payment or other payment owed to you by IDEXX any amounts owed by you to IDEXX.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">10.</TD><TD><U>IDEXX Property</U>. All IDEXX property in your possession must be returned by you to the Company no later than the Transition
Date; provided that your IDEXX-issued cell phone and laptop will be returned to you once all IDEXX proprietary information has
been removed. IDEXX will hold you responsible for any such property not returned and you hereby acknowledge and agree that IDEXX
may withhold the value of such property from any Transition Payment or other payment owed to you by IDEXX. You agree that with
respect to IDEXX documents and records, you shall not keep or retain any copies, either in hard copy or electronically stored.
As applicable in compliance with the foregoing, except as expressly set forth above, you agree to return by the Transition Date
to IDEXX all equipment, books, desktops, laptops, notebooks, documents, reports, files, memoranda, records, computer hardware or
software and program design samples, mockups, correspondence, work papers, financial data, business plans, business records, mailing
lists, customer or contact lists, calendars, card files, cardkey passes, door, file and computer keys, computer access codes or
disks, company charge cards, instructional or employee manuals, PDAs or other devices, and any other IDEXX property which you received,
compiled or made during your employment with IDEXX. Notwithstanding anything to the contrary in this Paragraph 10, you shall retain
access to and the right to use your IDEXX email address until December 31, 2019.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">11.</TD><TD><U>Administrative Assistance.</U> Following the Transition Date, the Company will consider in good faith requests made by you
from time to time for administrative and support services to be provided by Company employees during business hours.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">12.</TD><TD><U>Non-Disparagement</U>. You hereby agree that you shall not make any disparaging statements, whether orally, in writing,
or in any other medium regarding IDEXX or its directors, officers, shareholders, employees or agents. You also agree that you shall
not intentionally make any false or disparaging communications regarding IDEXX or its business, directors, officers, shareholders,
employees or agents, including but not limited to communicating any information (whether true or not) that may have the effect
of undermining the respect and confidence in IDEXX or its business, directors, officers, shareholders, employees or agents by IDEXX&rsquo;s
customers and/or employees. The Company hereby agrees that it shall not, and will direct its directors and officers that they shall
not, make any disparaging statements, whether orally, in writing, or in any other medium about you. The Company also agrees that
it shall not, and will direct its directors and officers that they shall not, intentionally make any false or disparaging communications
about you, including but not limited to communicating any information (whether true or not) that may have the effect of undermining
your reputation.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">13.</TD><TD><U>Choice of Law</U>. This Mutual Separation Agreement shall be governed by and construed in accordance with the laws of the
State of Maine. You agree and consent to submit to personal jurisdiction in the State of Maine in any state or federal court of
competent subject matter jurisdiction situated in Cumberland County, Maine. You further agree that the sole and exclusive venue
for any suit arising out of, or seeking to enforce, the terms of the Ancillary Agreements and the Release shall be in a state or
federal court of competent subject matter jurisdiction situated in Cumberland County, Maine. In addition, you waive any right to
challenge in another court any judgment entered by such Cumberland County court or to assert that any action instituted by the
Company in any such court is in the improper venue or should be transferred to a more convenient forum. <B>In addition, you and
the Company also waive any right you or it may otherwise have to a trial by jury in any action to enforce the terms of this Mutual
Separation Agreement, the Ancillary Agreements or the Release.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">14.</TD><TD><U>Confidentiality; Ancillary Agreements; Senior Advisory Agreement</U>. By signing this Mutual Separation Agreement, you are
representing that you will not use for yourself or for another company or disclose to others any information of a confidential
nature pertaining to IDEXX or its business that came or will come to your attention because of the positions or responsibilities
you have had or may in the future have with IDEXX. This includes, but is not limited to, customer contacts and information, financial
information, personnel information and any information concerning IDEXX&rsquo;s business strategies, which information is not known
by the general public by proper means.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">In addition, you acknowledge and confirm that simultaneously
herewith you are executing and delivering to the Company the Ancillary Agreements and the Senior Advisory Agreement, and, in each
case, will be subject to all of each agreement&rsquo;s respective terms and you hereby agree to comply with the restrictions thereunder.
You further acknowledge and agree that the Agreement Consideration the Company has agreed to pay and provide to you under this
Mutual Separation Agreement provide valuable and adequate consideration for your agreement to execute, be bound by and comply with
the Ancillary Agreements and the Release. You further acknowledge and agree that you will not challenge the enforceability of any
of the Ancillary Agreements or the Release and hereby agree to comply with the restrictions and obligations under such agreements.
You are further notified that if you file a lawsuit for retaliation by IDEXX for reporting a suspected violation of law, you may
disclose IDEXX&rsquo;s trade secrets to your attorney and use the trade secret information in the court proceeding if you (a) file
your document containing the trade secret under seal; and (b) do not disclose the trade secret, except pursuant to court order.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">In the event of any breach of any provision in this
Mutual Separation Agreement, or any of the Ancillary Agreements, in addition to any other remedy, you agree that the Company may
commence an action for equitable relief as it deems appropriate without the necessity of posting bond and without proving special
damages or irreparable injury.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">15.</TD><TD><U>Continuing Cooperation</U>. You and the Company have agreed that you will serve as Senior Advisor following the Transition
Date pursuant to the terms and conditions set forth in the Senior Advisory Agreement. In addition to providing the services pursuant
to the Senior Advisory Agreement, following the Transition Date, you agree to make yourself reasonably available (without the expectation
of additional compensation) to answer any questions via telephone/email about the transition of your responsibilities, and to cooperate
with respect to helping IDEXX deal with any legal matters arising out of events in which you were involved or with which you are
familiar due to your former or future roles and responsibilities with IDEXX.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">16.</TD><TD><U>Future Board Service</U>. Following the Transition Date you will continue to serve as a director of the Company and, with
respect to such service, you will be entitled to receive compensation as a non-employee director of the Company under the Company&rsquo;s
director compensation program as in effect from time to time. For this purpose, your status as a non-employee director shall be
deemed to be effective immediately following the Transition Date. You agree and acknowledge that, if, at any time, the Board determines
in its sole discretion to request that you step down from your role as a director of the Company and no longer serve in such capacity,
you will promptly tender your resignation as a director of the Company, and if you fail to tender such resignation on a timely
basis, you automatically will be deemed to have resigned as a director of the Company as of the date of such request from the Board
without further notice or action.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">17.</TD><TD><U>Complete Agreement</U>. This Mutual Separation Agreement, including the Ancillary Agreements and the Release, and the Senior
Advisory Agreement constitute the complete understanding between you and IDEXX with respect to your separation from employment
from IDEXX and your serving as Senior Advisor, and this Mutual Separation Agreement, including the Ancillary Agreements and the
Release, and the Senior Advisory Agreement supersede all prior representations, agreements, and understandings, both written and
oral, between you and IDEXX with respect to the subject matters hereof, including but not limited to the Employment Agreement and
the COC Agreement. You acknowledge that you have not relied upon any representations, promises, or agreements of any kind except
those set forth herein in signing this Mutual Separation Agreement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">18.</TD><TD><U>No Changes To Benefit Plans</U>. Nothing in this Mutual Separation Agreement shall be construed to modify the terms of any
IDEXX employee benefits plan. The terms of such plans shall continue to govern. IDEXX retains the right to amend or terminate its
employee benefit plans at any time.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">19.</TD><TD><U>Section 409A</U>. It is the intent of the parties that any compensation, benefits and other amounts payable or provided
under this Mutual Separation Agreement be paid or provided in a manner that is either exempt from, or in compliance with, Section
409A of the Code, as amended from time to time and related rules, regulations and Treasury pronouncements (together, &ldquo;<U>Section
409A</U>&rdquo;). Any ambiguity in this Mutual Separation Agreement shall be interpreted consistent with the foregoing. Each payment
payable hereunder shall be a separate payment in a series of separate payments for purposes of Section 409A. In no event whatsoever
shall the Company or its affiliates or their respective officers, directors, employees, or agents be liable for any additional
tax, interest or penalties that may be imposed on you by Section 409A or damages for failing to comply with or be exempt from Section
409A and no such person makes any guarantee that the Mutual Separation Agreement and the provisions thereof are exempt from or
comply with Section 409A. To the extent Section 409A is applicable, references to the end of your tenure as an employee or your
transition or separation, or like terms, shall mean a separation from service within the meaning of Section 409A and regulations
thereunder.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">20.</TD><TD><U>Effective Date</U>. Except as otherwise provided herein with respect to the Release, this Mutual Separation Agreement shall
take effect on the date of your execution of this Mutual Separation Agreement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">21.</TD><TD><U>Miscellaneous</U>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">a.</TD><TD>No delay or omission by the Company in exercising any right under this Mutual Separation Agreement shall operate as a waiver
of that or any other right. A waiver or consent given by the Company on any one occasion shall be effective only in that instance
and shall not be construed as a bar or waiver of any right on any other occasion.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">b.</TD><TD>The captions of the sections or paragraphs of this Mutual Separation Agreement are for convenience of reference only and in
no way define, limit or affect the scope or substance of any section of this Mutual Separation Agreement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">c.</TD><TD>In case any provision of this Mutual Separation Agreement shall be invalid, illegal or otherwise unenforceable, the validity,
legality and enforceability of the remaining provisions shall in no way be affected or impaired thereby.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">d.</TD><TD>Nothing in this Mutual Separation Agreement precludes you from providing truthful testimony when lawfully subpoenaed or otherwise
required to do so by law.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">e.</TD><TD>By signing this Mutual Separation Agreement, you hereby represent that to the best of your knowledge you did not commit any
act, or fail to commit any act, or do anything else while employed by IDEXX that was a breach of your duty of loyalty (including
but not limited to taking any property that belongs to IDEXX or its customers, except as otherwise expressly provided by this Mutual
Separation Agreement) or that might result in liability to IDEXX.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">f.</TD><TD>This Mutual Separation Agreement may not be altered, amended or modified except in writing signed by both the Company and you.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">g.</TD><TD>If any provision of this Mutual Separation Agreement shall be found by a court of competent jurisdiction to be invalid or unenforceable,
in whole or in part, then such provision shall be construed and/or modified or restricted to the extent and in the manner necessary
to render the same valid and enforceable, or shall be deemed excised from this Mutual Separation Agreement, as the case may require,
and this Mutual Separation Agreement shall be construed and enforced to the maximum extent permitted by law, as if such provision
had been originally incorporated herein as so modified or restricted, or as if such provision had not been originally incorporated
herein, as the case may be. The parties further agree to seek a lawful substitute for any provision found to be unlawful; provided,
that, if the parties are unable to agree upon a lawful substitute, the parties desire and request that a court or other authority
called upon to decide the enforceability of this Mutual Separation Agreement modify this Mutual Separation Agreement so that, once
modified, this Mutual Separation Agreement will be enforceable to the maximum extent permitted by the law in existence at the time
of the requested enforcement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">22.</TD><TD><U>Reimbursement; Cessation of Payment</U>. If you or your heirs or assigns breach any of the terms of this Mutual Separation
Agreement or breach any other obligation owed to the Released Parties (as defined in the Release), including, without limitation,
the Ancillary Agreements or the Release, IDEXX shall have, in addition to any other remedies, the right to cease any and all future
payments under this Mutual Separation Agreement provided in consideration thereof and the right to recover any and all payments
previously made under this Mutual Separation Agreement in consideration thereof, or any amount of actual damages proven by IDEXX,
if greater (except for the portion of the consideration received by you in consideration for your release of age discrimination
claims, which the parties hereby agree shall be equal to $1,000). Further, you shall indemnify and hold harmless the Released Parties
from and against all liability, costs and expenses, including attorneys&rsquo; fees, arising out of any said breach. You and IDEXX
acknowledge that the remedy set forth hereunder is not to be considered a form of liquidated damages and the tender back shall
not be the exclusive remedy hereunder. In the event of a breach of the terms of this Mutual Separation Agreement or the Ancillary
Agreements or breach of any other obligation owed to the Released Parties as set forth in the Release, IDEXX shall contact you
via email or written correspondence and provide you with five (5) business days&rsquo; notice to allow for your response to such
breach prior to the cessation of any and all future payments or benefits under this Mutual Separation Agreement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">23.</TD><TD><U>Counterparts</U>. This Mutual Separation Agreement may be executed in several counterparts, each of which shall be deemed
to be an original, but all of which together shall constitute one and the same instrument. Signatures delivered in .pdf format
shall be deemed effective for all purposes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #0B0B0B">Please
sign and return <B><I>a complete copy of this </I></B></FONT><B><I>Mutual Separation Agreement</I></B> <FONT STYLE="font-size: 10pt; color: #0B0B0B">to
Giovani Twigge, Chief Human Resources Officer of the Company. </FONT><FONT STYLE="font-size: 10pt; color: #1B1B1B">By executing
this Mutual Separation Agreement in the space provided below (and the </FONT><FONT STYLE="font-size: 10pt">Ancillary Agreements
<FONT STYLE="color: #1B1B1B">attached hereto), you agree to be bound by the terms of this Mutual Separation Agreement, (and the
terms of the </FONT>Ancillary Agreements attached hereto<FONT STYLE="color: #1B1B1B">), and IDEXX agrees to pay you the Agreement
Consideration and to provide the</FONT> Additional Option Vesting/Exercisability<FONT STYLE="color: #1B1B1B">, subject to you executing
and not revoking the Release in accordance with Paragraph 1.e. and the terms of the Release. </FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase; color: #1B1B1B">IDEXX
LABORATORIES, </FONT><FONT STYLE="text-transform: uppercase">INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1B1B1B">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: #1B1B1B; text-align: left"><FONT STYLE="font-size: 10pt">/s/
    Giovani Twigge</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: #1B1B1B"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: #1B1B1B"><FONT STYLE="font-size: 10pt">October
    23, 2019</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: #1B1B1B; text-align: left; width: 4%"><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: #1B1B1B; text-align: left; width: 45%"><FONT STYLE="font-size: 10pt">Giovani Twigge</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: #1B1B1B; width: 2%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: #1B1B1B; width: 49%"><FONT STYLE="font-size: 10pt">Date:</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: #1B1B1B; text-align: left; text-indent: 0"><FONT STYLE="font-size: 10pt">Title: </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: #1B1B1B; text-align: left; text-indent: 0"><FONT STYLE="font-size: 10pt">Corporate Vice President and</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: #1B1B1B; text-align: left; text-indent: 0; padding-left: 0.3in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: #1B1B1B; text-align: left"><FONT STYLE="font-size: 10pt">Chief Human Resources Officer</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1B1B1B">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 49%; font: 10pt Times New Roman, Times, Serif; color: #1B1B1B; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/
    Jonathan W. Ayers</FONT></TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; color: #1B1B1B"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 49%; font: 10pt Times New Roman, Times, Serif; color: #1B1B1B; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">October 23,
    2019</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: #1B1B1B; text-align: left"><FONT STYLE="font-size: 10pt">Jonathan
    W. Ayers</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: #1B1B1B"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: #1B1B1B"><FONT STYLE="font-size: 10pt">Date:</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Mutual Separation Agreement Signature
Page &ndash; Ayers]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B"><B></B></P>

<!-- Field: Page; Sequence: 9; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B"><B>Exhibit A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B"><B>[See attached Invention
and Non-Disclosure Agreement]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 24%; font-size: 10pt; text-align: left; padding-right: 1.1in; padding-left: 0.3in"><IMG SRC="tm19207851_ex10-1img01.jpg" ALT=""></TD>
    <TD STYLE="width: 76%; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">Invention
    and Non-Disclosure Agreement</FONT></TD></TR>
</TABLE>
<P STYLE="font: 13pt Times New Roman, Times, Serif; margin: 0pt 1.1in 0pt 0.3in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.1in 0pt 0.3in">I, <FONT STYLE="color: #1B1B1B">Jonathan W. Ayers,
</FONT>hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.1in 0pt 0.3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15in"><B>1. Inventions and Patents</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.3in"></TD><TD STYLE="width: 0.3in">(a)</TD><TD>I will promptly and fully disclose to IDEXX Laboratories, Inc. (together with its subsidiaries and affiliates, the &ldquo;Company&rdquo;)
any and all inventions, discoveries, trade secrets and improvements, whether or not patentable or whether or not they are made,
conceived or reduced to practice during working hours or using the Company&rsquo;s data or facilities, which I have developed,
made, conceived or reduced to practice, or may develop, make, conceive or reduce to practice, during my employment by the Company
or while providing services to the Company as a Senior Advisor , either solely or jointly with others (collectively, &ldquo;Developments&rdquo;).
All such Developments are and shall be the sole property of the Company, and I hereby assign to the Company, without further compensation,
all my right, title and interest in and to such Developments and any and all related patents, patent applications, copyrights,
copyright applications, trademarks and trade names in the United States and elsewhere.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.3in"></TD><TD STYLE="width: 0.3in">(b)</TD><TD STYLE="padding-right: 0.25in">I will keep and maintain adequate and current written records of all Developments (in the form
of notes, sketches, drawings, and as may be specified by the Company), which records shall be available to and remain the sole
property of the Company at all times.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.3in"></TD><TD STYLE="width: 0.3in">(c)</TD><TD>I will assist the Company in obtaining and enforcing patent, copyright and other forms of legal protection for the Developments
in any country. Upon request, I will sign all applications, assignments, instruments, and papers and perform all acts necessary
or desired by the Company and to enable the Company, its successors, assigns and nominees, to secure and enjoy the full exclusive
benefits and advantages thereof.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.3in"></TD><TD STYLE="width: 0.3in">(d)</TD><TD STYLE="padding-right: 0.1in">I understand that my obligations under this section will continue after the termination of my
employment with the Company and after the end of the period during which I am providing services to the Company as a Senior Advisor
(the &ldquo;Senior Advisory Period&rdquo;) and that during my employment and the Senior Advisory Period I will perform such obligations
without further compensation, except for reimbursement of expenses incurred at the request of the Company. I further understand
that if after the Senior Advisory Period I am requested to perform any obligations under the section, I shall receive for such
performance a reasonable per diem fee, as well as reimbursement of any expenses incurred at the request of the Company.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15in"><B>2. Proprietary Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.3in"></TD><TD STYLE="width: 0.3in">(a)</TD><TD>I recognize that my relationship with the Company has been and is, and will continue to be, one of high trust and confidence
by reason of my access to and contact with the trade secrets and confidential and propriety information of the Company and its
employment applicants, employees, customers and contractors. I will not at any time, during my the remaining period of my employment,
during the Senior Advisory Period or thereafter, disclose to others, or use for my own benefit or the benefit of others, any of
the Developments or any confidential, proprietary or secret information owned, possessed or used by the Company or its employment
applicants, employees, customers or contractors (collectively, &ldquo;Proprietary Information&rdquo;). I understand that notwithstanding
the foregoing, nothing in this Invention and Non-Disclosure Agreement prohibits me from reporting to any governmental official
or an attorney information concerning a possible violation of law, and that I may disclose trade secret information to a government
official or to an attorney and use it in certain court proceedings without fear of prosecution or liability provided I do so consistent
with 18 U.S.C. 1833, as amended.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.3in"></TD><TD STYLE="width: 0.3in">(b)</TD><TD STYLE="padding-right: 0.1in">By way of illustration, but not limitation, Proprietary Information includes trade secrets, processes,
data, know-how, marketing plans, forecasts, unpublished financial statements, budgets, licenses, prices, costs and employee, customer
and supplier lists, and all employment applicant, employee or customer personal information.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.3in"></TD><TD STYLE="width: 0.3in">(c)</TD><TD STYLE="padding-right: 0.1in">My undertakings and obligations under this Section 2 will not apply, however, to any Proprietary
Information which: (a) is or becomes generally known to the public through no action on my part, (b) is generally disclosed to
third parties by the Company without restriction on such third parties, or (c) is required to be disclosed by me within the scope
of my duties to the Company.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #475764">&copy; 2016 IDEXX Laboratories, Inc. All rights
reserved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #475764">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #475764"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #475764">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 24%; font-size: 10pt; text-align: left; padding-right: 1.1in; padding-left: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="tm19207851_ex10-1img01.jpg" ALT="" STYLE="height: 26px; width: 131px"></FONT></TD>
    <TD STYLE="width: 76%; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">Invention and Non-Disclosure Agreement</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.55in; text-indent: -0.2in">(d) Upon termination of my employment
with the Company, and at the end of the Senior Advisory Period, or at any other time upon request of the Company, I will promptly
deliver to the Company all notes, memoranda, notebooks, drawings, records, reports, files and other documents (and all copies or
reproductions of such materials) in my possession or under my control, whether prepared by me or others, which contain Proprietary
Information. I acknowledge that this material is the sole property of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.55in; text-indent: -0.2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15in"><B>3.</B> <B>Absence of Restrictions Upon Disclosure
and Competition</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.35in"></TD><TD STYLE="width: 0.2in">(a)</TD><TD>I hereby represent that, except as I have disclosed in writing to the Company, I am not bound by the terms of any agreement
with any previous employer or other party to refrain from using or disclosing trade secret or confidential or proprietary information
in the course of my employment with, or service as Senior Advisor to, the Company or to refrain from competing, directly or indirectly,
with the business of such previous employer or any other party.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.35in"></TD><TD STYLE="width: 0.2in">(b)</TD><TD>I further represent that my performance of all the terms of this Agreement and as an employee of and Senior Advisor to the
Company does not and will not breach any agreement to keep in confidence proprietary information, knowledge or data acquired by
me in confidence or in trust prior to my employment with the Company, and I have not and will not disclose to the Company or induce
the Company to use any confidential and proprietary information or material belonging to any previous employer or others.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15in"><B>4.</B> <B>Other Obligations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in">I acknowledge that the Company from time to time
may have agreements with other persons or with the U. S. Government, or agencies thereof, which impose obligations or restrictions
on the Company regarding inventions made during the course of work under such agreements or regarding the confidential nature of
such work. I agree to be bound by all such obligations and restrictions, which are made known to me, and to take all action necessary
to discharge the obligations of the Company under such agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in"><B>Miscellaneous</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.35in"></TD><TD STYLE="width: 0.2in">(a)</TD><TD STYLE="padding-right: 1.2in">The invalidity or unenforceability of any provision of this Agreement shall not affect the validity
or enforceability of any other provision of this Agreement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.35in"></TD><TD STYLE="width: 0.2in">(b)</TD><TD STYLE="padding-right: 0.8in">This Agreement supersedes all prior agreements, written or oral, between me and the Company relating
to the subject matter of this Agreement. This Agreement may not be modified, changed or discharged in whole or in part, except
by an agreement in writing signed by me and the Company. I agree that any change or changes in my duties, salary or compensation
after the signing of this Agreement shall not affect the validity or scope of this Agreement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.35in"></TD><TD STYLE="width: 0.2in">(c)</TD><TD STYLE="padding-right: 0.85in">This Agreement will be binding upon my heirs, executors and administrators and will inure to
the benefit of the Company and its successors and assigns.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.35in"></TD><TD STYLE="width: 0.2in">(d)</TD><TD STYLE="padding-right: 0.75in">No delay or omission by the Company in exercising any right under this Agreement will operate
as a waiver of that or any other right. A waiver or consent given by the Company on any one occasion is effective only in that
instance and will not be construed as a bar to or waiver of any right on any other occasion.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.35in"></TD><TD STYLE="width: 0.2in">(e)</TD><TD STYLE="padding-right: 0.8in">I expressly consent to be bound by the provisions of this Agreement for the benefit of the Company
or any subsidiary or affiliate thereof to whose employ I may be transferred without the necessity that this Agreement be re-signed
at the time of such transfer.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.35in"></TD><TD STYLE="width: 0.2in">(f)</TD><TD STYLE="padding-right: 0.8in">This Agreement is governed by and will be construed as a sealed instrument under and in accordance
with the laws of the State of Maine.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0; text-align: justify">I have read all of the provisions
of the IDEXX Invention and Non-Disclosure Agreement and I understand, and agree to, each of such provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: bottom; font-size: 10pt">
    <TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif">Signature:</TD>
    <TD STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 50%; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-size: 10pt">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Printed Name:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-size: 10pt">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Date Signed:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0">&copy; 2016 IDEXX Laboratories, Inc. All rights reserved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B"><B>Exhibit B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B"><B>[See Attached Non-Compete
Agreement]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0.45pt 0pt 0; color: #CC0000"><IMG SRC="tm19207851_ex10-1img02.jpg" ALT=""><B></B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0.45pt 0pt 0; color: #CC0000"><B>Non-Compete
Agreement</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0.45pt 0pt 0; color: #CC0000"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35in 0pt 0.05in">I, <FONT STYLE="color: #1B1B1B">Jonathan W.
Ayers,</FONT> hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35in 0pt 0.05in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in">1. <B>Non-Compete</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in">While I continue to be employed by, or serve as a
Senior Advisor (as defined in the Mutual Separation Agreement) to or a director of IDEXX Laboratories, Inc. (together with its
subsidiaries and affiliates, the &ldquo;Company&rdquo;) and for a period equal to the greater of (x) two (2) years after all such
services to the Company ends (whether as a Senior Advisor or director) and (y) while any of my Outstanding Stock Options (as defined
in the Mutual Separation Agreement, dated October 23, 2019, between the Company and me (the &ldquo;Mutual Separation Agreement&rdquo;))
continue to vest under the terms of the Mutual Separation Agreement, I will not directly or indirectly:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.55in; text-align: left; text-indent: -0.25in">(a)&nbsp;&nbsp;&nbsp;Engage (whether for compensation or without compensation) as an individual proprietor, independent contractor, consultant, partner,
stockholder, officer, employee, director, joint venturer, investor, lender, or in any other capacity whatsoever (otherwise than
as the holder of not more than one percent (1%) of the total outstanding stock of a publicly held company) in any business enterprise
which competes with the Company in any business area in which the Company is engaged including, but not limited to, the animal
and agricultural diagnostic field and the food and environmental testing field; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0.3in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.55in; text-align: left; text-indent: -0.25in">(b)&nbsp;&nbsp;&nbsp;Recruit
or otherwise solicit or induce any employee of the Company to terminate their employment with, or otherwise cease their relationships
with, the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 22.5pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.55in; text-align: left; text-indent: -0.25in">(c)&nbsp;&nbsp;&nbsp;Directly or indirectly induce or solicit (or assist any Person (as defined below) to induce or solicit) any customer, vendor, supplier,
or client of the Company to terminate its relationship or otherwise cease doing business in whole or in part with the Company ,
or directly or indirectly interfere with (or assist any Person to interfere with) any material relationship between the Company
and any of its customers, vendors, suppliers, or clients so as to cause harm to the Company ; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 22.5pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.55in; text-align: left; text-indent: -0.25in">(d)&nbsp;&nbsp;&nbsp;&nbsp;Become
employed by or otherwise provide any services to the companies set forth on Addendum A attached hereto and their respective affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 22.5pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 22.5pt; text-align: left">As used herein, &ldquo;Person&rdquo;
shall mean any individual, corporation, partnership, limited liability company, association, trust or other entity or organization,
including a government or political subdivision or an agency or instrumentality thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 22.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in">2. <B>Interpretation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in 0pt 0.05in">I consider the restrictions against competition
set forth in Section 1 to be reasonable for the purposes of protecting the business of the Company. However, if any such restriction
is found by any court of competent jurisdiction to be unenforceable because it extends for too long a period of time or over too
great a range of activities or in too broad a geographic area, I agree that it shall be interpreted to extend only over the maximum
period of time, range of activities or geographic area as to which it may be enforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in 0pt 0.05in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in">3. <B>Miscellaneous</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.55in; text-align: left; text-indent: -0.25in">(a)&nbsp;&nbsp;&nbsp;&nbsp;The
invalidity or unenforceability of any provision of this agreement shall not affect the validity or enforceability of any other
provision of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.55in; text-align: left; text-indent: -0.25in">(b)&nbsp;&nbsp;&nbsp;This
Agreement will be binding upon my heirs, executors and administrators and will inure to the benefit of the Company and its successors
and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.55in; text-align: left; text-indent: -0.25in">(c)&nbsp;&nbsp;&nbsp;No
delay or omission by the Company in exercising any right under this Agreement will operate as a waiver of that or any other right.
A waiver or consent given by the Company on any one occasion is effective only in that instance and will not be construed as a
bar to or waiver of any right on any other occasion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.55in; text-align: left; text-indent: -0.25in">(e)&nbsp;&nbsp;&nbsp;I expressly
consent to be bound by the provisions of this Agreement for the benefit of the Company or any subsidiary or affiliate thereof to
whose employ I may be transferred without the necessity that this Agreement be re-signed at the time of such transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.55in; text-align: left; text-indent: -0.25in">(f)&nbsp;&nbsp;&nbsp;This Agreement is governed by and will be construed as a sealed instrument under and in accordance with the laws of the State of
Maine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0.05in; text-align: justify">I have read all of the provisions
of this IDEXX Non-Compete Agreement and I understand, and agree to, each of such provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0.05in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 8%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 0.05in">Signature:</TD>
    <TD STYLE="width: 39%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 0.05in; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Date Signed:</TD>
    <TD STYLE="width: 38%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0.05in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.05in">Printed Name:</TD>
    <TD STYLE="width: 90%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.05in; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0.05in; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B"><B></B></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B"><B>Exhibit C</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B"><FONT STYLE="font-variant: small-caps"><B>You
should consult with an attorney before signing this release of claims.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B"><B>RELEASE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B">Capitalized terms used in
this release and defined in the Mutual Separation Agreement (defined below) shall have the meanings given to such terms under the
Mutual Separation Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>In
consideration of the payments and benefits to be made under the Mutual Separation Agreement, dated as of October 23, 2019 (the
 &ldquo;<U>Mutual Separation Agreement</U>&rdquo;), by and between Jonathan W. Ayers (the &ldquo;<U>Employee</U>&rdquo; or &ldquo;<U>you</U>&rdquo;)
and IDEXX Laboratories, Inc. (the &ldquo;<U>Company</U>&rdquo;), its subsidiaries and affiliates (hereinafter collectively referred
to as &ldquo;<U>IDEXX</U>&rdquo;), the sufficiency of which you acknowledge, by signing this general release of claims (the &ldquo;<U>Release</U>&rdquo;),
you and your heirs and assigns hereby fully, forever, irrevocably and unconditionally release and discharge IDEXX Laboratories,
Inc., its subsidiaries and affiliates, and all of their respective former and current officers, directors, owners, stockholders,
affiliates, agents, employees, and attorneys (collectively the &ldquo;<U>Released Parties</U>&rdquo;) from, and waive, any and
all claims, charges, or actions of any kind which you have ever had or now have through the Release Effective Date (as defined
in Paragraph 4.h below), whether known or unknown, against any or all of the Released Parties, arising out of or relating to your
employment or termination from employment, including but not limited to claims under the Employment Agreement, claims under the
Severance Plan, the COC Agreement, claims for discrimination based on race, sex, disability, national origin, age, religion, color,
ancestry, marital or family status, pregnancy, sexual orientation, and any other legally protected attribute or status, and including
without limitation claims under Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Rehabilitation Act
of 1973, the Employee Retirement Income Security Act, the Equal Pay Act, the Americans with Disabilities Act, the Family and Medical
Leave Act, the National Labor Relations Act, the Maine Human Rights Act, and all other applicable state laws, including but not
limited to, laws pertaining to wrongful discharge claims, defamation claims, retaliation claims, unpaid wage claims, or other
statutory or common law or contract claims. You acknowledge that this release releases the Released Parties in both their corporate
and their individual capacities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Without limiting the above, this Release
also constitutes a release of any claims you may have, as of the Release Effective Date, against the Released Parties, pursuant
to the Age Discrimination in Employment Act, as amended (which is the federal statute which makes it illegal for an employer to
discharge or otherwise discriminate against an employee because of the employee&rsquo;s age), including any possible claims relating
to termination of your employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">It is the specific intent and purpose of
this Release to release and discharge any and all claims and causes of action of any kind or nature whatsoever as aforesaid to
the full extent such release is allowed by law, from the beginning of time until the present day, whether such claims and causes
of action are known or unknown and whether specifically mentioned or not. You acknowledge that you are aware that statutes exist
that render null and void releases and discharges of claims and causes of actions that are unknown to the releasing or discharging
party at the time of execution of the release and discharge. You hereby expressly waive, surrender and agree to forego any protection
to which you would otherwise be entitled by virtue of the existence of any such statute in any jurisdiction, including, but not
limited to, the State of Maine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Release &ndash; Pg. <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You agree not only to release and discharge
the Released Parties from any and all claims against the Released Parties that you could make on your own behalf, but also those
which may have been or may be made by any other person or organization on your behalf.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You specifically waive any right to become,
and promise not to become, a party to any case or proceeding or a member of any class in a case or proceeding in which any claim
or claims are asserted against the Released Parties involving any event which has occurred prior to or as of the Transition Date.
If you are asserted to be a member of a class in a case or proceeding against the Released Parties involving any events occurring
prior to or as of the Release Effective Date, you shall immediately withdraw with prejudice in writing from said class, if permitted
by law to do so. You agree that this Release is, will constitute and may be pleaded as a bar to any such case or proceeding. You
represent that you have no lawsuits, claims or actions pending in your name, or on behalf of any other person or entity, against
the Released Parties and that you do not intend to bring any lawsuits, claims or actions on your own behalf or on behalf of any
other person or entity against any Released Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Exceptions
to the Release</U>. Notwithstanding the Release set forth above in Paragraph 1 of this Release and subject, without limitation,
to your compliance with Paragraphs 12 and 14 of the Mutual Separation Agreement, this Release is not a waiver by you of (1) any
right or claim that may arise after the Release Effective Date, (2) any right or claim to unemployment compensation, (3) any vested
retirement and profit sharing benefits for which you are eligible in accordance with the terms of the respective employee benefit
plans, (4) your right to indemnification from the Company under the certificate of incorporation or bylaws of the Company and
in accordance with applicable law, or (5) any rights under this Release or the Mutual Separation Agreement or that may not be
released by law. This is also not a waiver of any claim you may have for workers&rsquo; compensation benefits although you hereby
represent to IDEXX that you do not know of any such claims and that you do not believe that you have any workplace injury relating
to your employment with IDEXX. Further, nothing in this Release or the Mutual Separation Agreement will be construed to affect
the independent right and responsibility of the Equal Employment Opportunity Commission (&ldquo;<U>EEOC</U>&rdquo;) or a state
or local fair employment practices agency acting as an EEOC referral agency to enforce employment discrimination laws. Signing
this Release will not interfere with your right to file a charge or participate in an investigation or proceeding conducted by
the EEOC or the state or local agency as long as you do not seek or accept any damages, remedies, or other relief for yourself
personally, which you promise not to do, and any right to which you specifically waive. You understand that unless a court invalidates
this Release, you have no right to recover damages against the Released Parties for your claims. <FONT STYLE="color: #191919">Notwithstanding
anything to the contrary contained herein, no provision of this Release or the </FONT>Mutual Separation Agreement <FONT STYLE="color: #191919">shall
be interpreted so as to impede you (or any other individual) from reporting possible violations of federal law or regulation to
any governmental agency or entity, including but not limited to the Department of Justice, the Securities and Exchange Commission,
the United States Congress, and any agency Inspector General, or making any other disclosures under the whistleblower provisions
of United States federal law or regulation. You do not need the prior authorization of IDEXX to make any such reports or disclosures
and you shall not be required to notify IDEXX that such reports or disclosures have been made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Release &ndash; Pg. <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>No
Admissions</U>. Nothing contained herein shall be construed as an admission by IDEXX of any liability or unlawful conduct whatsoever.
You agree and understand that the payments and benefits described in the Mutual Separation Agreement are provided solely in consideration
of your execution of this Release and your obligations under the Ancillary Agreements, and that the payments and benefits are
sufficient consideration for the Release and the terms of the Mutual Separation Agreement and your obligations under the Ancillary
Agreements</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Knowing
Consent to Release</U>. By signing below you understand and agree that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">a.</TD><TD>You have the option to take a full <B>twenty-one (21) days</B> from October 23, 2019, the date the Release was provided to
you by the Company, within which to consider this Release before executing it. If you sign this Release sooner than 21 days from
when it was provided to you, you do so with the understanding that you could have taken the entire 21-day period to review this
Release.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">b.</TD><TD>You have carefully read and fully understand all of the provisions of this Release.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">c.</TD><TD>You are, through this Release, releasing the Released Parties from any and all claims you may have against the Released Parties.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">d.</TD><TD>You knowingly and voluntarily agree to all of the terms set forth in this Release.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">e.</TD><TD>You knowingly and voluntarily intend to be legally bound by the same.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">f.</TD><TD>You have been advised in writing to consider the terms of this Release and consult with an attorney of your choice prior to
executing this Release.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">g.</TD><TD>You acknowledge that the Agreement Consideration set forth in the Mutual Separation Agreement provides valuable and adequate
consideration for this Release and your obligations under the Ancillary Agreements.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">h.</TD><TD>You have a full <B>seven (7) days after</B> executing this Release to revoke this Release by delivering written notice of revocation
to Giovani Twigge, Chief Human Resources Officer of the Company, and are hereby advised in writing that this Release shall not
become effective or enforceable until the revocation period has expired. If the Release is not revoked, it shall become effective
and irrevocable on the day next following the day on which the foregoing revocation period has expired (the &ldquo;<U>Release Effective
Date</U>&rdquo;). In case of revocation, the obligations of each party to this Release and the Mutual Separation Agreement (including
the obligation of the Company to provide the Agreement Consideration) shall become null and void.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Release &ndash; Pg. <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Choice
of Law</U>. This Release shall be governed by and construed in accordance with the laws of the State of Maine. You agree and consent
to submit to personal jurisdiction in the State of Maine in any state or federal court of competent subject matter jurisdiction
situated in Cumberland County, Maine. You further agree that the sole and exclusive venue for any suit arising out of, or seeking
to enforce, the terms of this Release, the Mutual Separation Agreement and the Ancillary Agreements shall be in a state or federal
court of competent subject matter jurisdiction situated in Cumberland County, Maine. In addition, you waive any right to challenge
in another court any judgment entered by such Cumberland County court or to assert that any action instituted by IDEXX in any
such court is in the improper venue or should be transferred to a more convenient forum. <B>In addition, you and IDEXX also waive
any right you or it may otherwise have to a trial by jury in any action to enforce the terms of this Release.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">a.</TD><TD>No delay or omission by IDEXX in exercising any right under this Release shall operate as a waiver of that or any other right.
A waiver or consent given by IDEXX on any one occasion shall be effective only in that instance and shall not be construed as a
bar or waiver of any right on any other occasion.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">b.</TD><TD>The captions of the sections or paragraphs of this Release are for convenience of reference only and in no way define, limit
or affect the scope or substance of any section or paragraph of this Release.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">c.</TD><TD>In case any provision of this Release shall be invalid, illegal or otherwise unenforceable, the validity, legality and enforceability
of the remaining provisions shall in no way be affected or impaired thereby.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">d.</TD><TD>Nothing in this Release precludes you from providing truthful testimony when lawfully subpoenaed or otherwise required to do
so by law.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">e.</TD><TD>By signing this Release, you hereby represent that to the best of your knowledge you did not commit any act, or fail to commit
any act, or do anything else while employed by IDEXX that was a breach of your duty of loyalty (including but not limited to taking
any property that belongs to IDEXX or its customers) or that might result in liability to IDEXX.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">f.</TD><TD>This Release may not be altered, amended or modified except in writing signed by both IDEXX and you.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">g.</TD><TD>If any provision of this Release shall be found by a court of competent jurisdiction to be invalid or unenforceable, in whole
or in part, then such provision shall be construed and/or modified or restricted to the extent and in the manner necessary to render
the same valid and enforceable, or shall be deemed excised from this Release, as the case may require, and this Release shall be
construed and enforced to the maximum extent permitted by law, as if such provision had been originally incorporated herein as
so modified or restricted, or as if such provision had not been originally incorporated herein, as the case may be. The parties
further agree to seek a lawful substitute for any provision found to be unlawful; provided, that, if the parties are unable to
agree upon a lawful substitute, the parties desire and request that a court or other authority called upon to decide the enforceability
of this Release modify this Release so that, once modified, this Release will be enforceable to the maximum extent permitted by
the law in existence at the time of the requested enforcement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Release &ndash; Pg. <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Complete
Agreement</U>. This Release, the Mutual Separation Agreement and the Ancillary Agreements constitute the complete understanding
between you and IDEXX with respect to your separation from employment, and this Release supersedes all prior representations,
agreements, and understandings, both written and oral, between you and IDEXX with respect to the subject matters hereof, including
but not limited to the Employment Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Counterparts</U>.
This Release may be executed in several counterparts, each of which shall be deemed to be an original, but all of which together
shall constitute one and the same instrument. Signatures delivered in .pdf format shall be deemed effective for all purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1B1B1B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1B1B1B"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Release &ndash; Pg. <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1B1B1B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; color: #0B0B0B">Please sign and return <B><I>a
complete copy of this Release </I></B>to Giovani Twigge, Chief Human Resources Officer of the Company, indicating your agreement
to all of the terms of the Release. This Release shall expire if not signed by you and returned to Giovani Twigge by no later than
the close of business on November 13, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1B1B1B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1B1B1B">For IDEXX</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1B1B1B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 6in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 49%; font: 10pt Times New Roman, Times, Serif; color: #1B1B1B; border-top: Black 1pt solid"><FONT STYLE="font-size: 10pt">By:</FONT></TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; color: #1B1B1B"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 49%; font: 10pt Times New Roman, Times, Serif; color: #1B1B1B; border-top: Black 1pt solid"><FONT STYLE="font-size: 10pt">Date:</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: #1B1B1B"><FONT STYLE="font-size: 10pt">Title:</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1B1B1B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0B0B0B"><B>You have been advised that at least twenty-one
(21) calendar days will be provided for the review of this Release, and to consult with an attorney prior to the execution of this
Release.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0B0B0B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0B0B0B"><B>You represent and agree that you have carefully
read and fully understand all of the provisions of this Release and that you have voluntarily entered into this Release.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0B0B0B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accepted and Agreed To:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 49%; font: 10pt Times New Roman, Times, Serif; color: #1B1B1B; text-align: left; border-top: Black 1pt solid">Jonathan W. Ayers</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; color: #1B1B1B">&nbsp;</TD>
    <TD STYLE="width: 49%; font: 10pt Times New Roman, Times, Serif; color: #1B1B1B; border-top: Black 1pt solid">Date:</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1B1B1B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1B1B1B"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Release Signature Page &ndash; Ayers]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 20; Options: NewSection Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>tm19207851_ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Execution Copy</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">October 23, 2019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Jonathan W. Ayers</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Re: Senior Advisory Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Jon:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This letter agreement (this &ldquo;<U>Senior
Advisory Agreement</U>&rdquo;), confirms the mutual agreement between you and IDEXX Laboratories, Inc. (the &ldquo;<U>Company</U>,&rdquo;
and together with its subsidiaries and affiliates, &ldquo;<U>IDEXX</U>&rdquo;) for you to serve as senior advisor to the Company
(&ldquo;<U>Senior Advisor</U>&rdquo;) and provide certain advisory services to IDEXX. By signing below you agree to the terms and
conditions set forth in this Advisory Agreement, and agree and acknowledge the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Engagement</U></B>.
Subject to and upon the terms and conditions of this Advisory Agreement, the Company hereby engages you as Senior Advisor to provide
Advisory Services (as defined below) to IDEXX during the Advisory Term (as defined below), and you agree to render Advisory Services
to IDEXX during the Advisory Term. It is agreed by the parties hereto that during the Advisory Term you will at all times be considered
an independent contractor and not an employee of IDEXX.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Advisory
Services</U></B>. During the Advisory Term, you shall provide advice and services relating to such issues and projects as shall
be identified from time to time and mutually agreed by you and the President and Chief Executive Officer of the Company (the &ldquo;<U>CEO</U>&rdquo;)
(collectively, the &ldquo;<U>Advisory Services</U>&rdquo;). You agree and acknowledge that you shall not have any authority, power
or right to (i) execute or deliver any contract, agreement or instrument on behalf of IDEXX (ii) take any action on behalf of or
bind IDEXX, or (iii) hold yourself out to have such authority, power or right.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Compensation</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.25in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>As compensation for providing the Advisory Services, you shall receive from the Company advisory fees (&ldquo;<U>Advisory
Fees</U>&rdquo;) at a rate of $240,000 per annum, payable in installments of $60,000 on each February 1, May 1, August 1 and November
1 (each a &ldquo;<U>Payment Date</U>&rdquo;) during the Advisory Term; provided that (i) in the event that any Payment Date falls
other than on a business day, the installment otherwise payable on such Payment Date shall instead be paid to you on the first
business day occurring after such Payment Date; and (ii) in the event that the Advisory Term ends between Payment Dates, the final
payment hereunder shall be paid to you as soon as practicable following the end of the Advisory Term and be in an amount equal
to $60,000 multiplied by a fraction the numerator of which shall be the number of calendar days from and including the prior Payment
Date through the last day of the Advisory Term and the denominator of which will be the number of calendar days from and including
the prior Payment Date through the day prior to the next Payment Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; text-align: center">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.25in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>You acknowledge and agree that, from and after the commencement of the Advisory Term, you will not be an &ldquo;employee&rdquo;
(or person of similar status) of IDEXX for purposes of the Internal Revenue Code of 1986, as amended from time to time and the
related rules, regulations and Treasury pronouncements (the &ldquo;<U>Code</U>&rdquo;) or for purposes of participation in any
and all employee benefit plans of IDEXX. Accordingly, all Advisory Fees or other payments paid or made to you under this Advisory
Agreement or otherwise shall be paid or made without withholding or deduction of any kind, and you shall assume sole responsibility
for discharging all tax and other obligations associated therewith. You further acknowledge and agree that you have no right to
participate, and shall not participate, in any employee benefit plans, programs or policies of IDEXX, except as provided under
the Mutual Separation Agreement, dated as of the date hereof, between you and the Company (the &ldquo;<U>Mutual Separation Agreement</U>&rdquo;)
with respect to benefits accrued, vested or earned prior to the beginning of the Advisory Term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Advisory
Term</U>. </B>The term of this Senior Advisory Agreement (the &ldquo;<U>Advisory Term</U>&rdquo;) shall commence as of November
2, 2019 and shall continue in effect until terminated by either you or the Company by providing to the other ninety (90) days&rsquo;
written notice of termination of the Advisory Term; provided that the Company may elect to provide you with less than ninety (90)
days&rsquo; written notice of termination of the Advisory Term, in which case, solely for purposes of determining the end of the
Advisory Term and applicable Advisory Fee due pursuant to Section 3(a), the Advisory Term shall be deemed to end ninety (90) days
after the date you are provided with such written notice of termination by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Section
409A</U></B>. It is the intent that any compensation, benefits and other amounts payable or provided under this Senior Advisory
Agreement be paid or provided in a manner that is either exempt from, or in compliance with, Section 409A of the Code (&ldquo;<U>Section
409A</U>&rdquo;). Any ambiguity in this Senior Advisory Agreement shall be interpreted consistent with the foregoing. In that connection,
it is the intention of the Company and you that the time spent by you providing the Advisory Services will constitute no more than
20% of the average time you spent providing services to the Company as an employee of the Company during the 36 months immediately
prior to the commencement of the Advisory Term, calculated in accordance with Section 409A. Each payment payable hereunder shall
be a separate payment in a series of separate payments for purposes of Section 409A. In no event whatsoever shall the Company or
its affiliates or their respective officers, directors, employees, or agents be liable for any additional tax, interest or penalties
that may be imposed on you by Section 409A or damages for failing to comply with or be exempt from Section 409A and no such person
makes any guarantee that this Senior Advisory Agreement and the provisions hereof are exempt from or comply with Section 409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Indemnification</U></B>. The Company
shall indemnify you and hold you harmless from and against all expenses (including reasonable attorneys&rsquo; fees), judgments,
fines and amounts paid in settlement actually and reasonably incurred by you in connection with any action, suit or proceeding
threatened or brought by any third-party by reason of your performance of Advisory Services hereunder, except to the extent it
is finally determined by a court of competent jurisdiction or the final disposition of any other proceeding that you engaged in
gross negligence or willful misconduct.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; text-align: center">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Compliance
with IDEXX Policies; Restrictive Covenants</U></B>. You confirm and agree that, during the Advisory Term, you shall be subject
to, and shall comply with, the Company&rsquo;s Code of Ethics and all Company policies and procedures relevant to the Advisory
Services you are providing. In addition, you confirm and agree that you are bound by the Ancillary Agreements (as defined in the
Mutual Separation Agreement) for the duration of the Advisory Term and for such period thereafter as set forth in the Ancillary
Agreements, and that the provisions related to the compliance and enforcement of the Ancillary Agreements set forth in the Mutual
Separation Agreement shall continue to apply and shall be deemed to be incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Return
of IDEXX Property</U></B>. You agree that, promptly after the end of the Advisory Term, you will return to the Company all IDEXX
property in your possession In that connection, you agree to return to the Company promptly after the end of the Advisory Term
all equipment, books, desktops, laptops, notebooks, documents, reports, files, memoranda, records, computer hardware or software
and program design samples, mockups, correspondence, work papers, financial data, business plans, business records, mailing lists,
customer or contact lists, calendars, card files, cardkey passes, door, file and computer keys, computer access codes or disks,
manuals, PDAs or other devices, and any other IDEXX property which you received, compiled or made during, or prior to, the Advisory
Term, except as otherwise expressly agreed in the Mutual Separation Agreement. In furtherance of the foregoing, you agree that
with respect to IDEXX documents and records, you shall not keep or retain any copies, either in hard copy or electronically stored,
on any topic following the Advisory Term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Governing
Laws and Enforcement</U></B>.&nbsp;This Senior Advisory Agreement shall be governed by and construed in accordance with the laws
of the State of Maine. You agree and consent to submit to personal jurisdiction in the State of Maine in any state or federal
court of competent subject matter jurisdiction situated in Cumberland County, Maine. In addition, you waive any right to challenge
in another court any judgment entered by such Cumberland County court or to assert that any action instituted by the Company in
any such court is in the improper venue or should be transferred to a more convenient forum. <B>In addition, you and the Company
also waive any right you or it may otherwise have to a trial by jury in any action to enforce the terms of this Senior Advisory
Agreement</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Complete
Agreement</U></B>. This Senior Advisory Agreement, and the Mutual Separation Agreement, including the Ancillary Agreements and
the Release attached thereto, constitute the complete understanding between you and IDEXX with respect to your separation from
employment from IDEXX and your serving as Senior Advisor; and this Senior Advisory Agreement and the Mutual Separation Agreement,
including the Ancillary Agreements (as defined in the Mutual Separation Agreement) and the Release attached thereto, supersede
all prior representations, agreements, and understandings, both written and oral, between you and IDEXX with respect to the subject
matters hereof, including but not limited to that certain Employment Agreement, dated January 22, 2002, between you and the Company
and that certain Amended and Restated Executive Employment Agreement dated February 13, 2011 by and between you and the Company.
You confirm and agree that nothing contained in this Senior Advisory Agreement is intended to supersede any provisions of the Mutual
Separation Agreement, including the Ancillary Agreements and Release. You acknowledge that you have not relied upon any representations,
promises, or agreements of any kind except those set forth herein in signing this Senior Advisory Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; text-align: center">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>No
Assignment</U></B>. Neither you nor the Company will assign, transfer, or subcontract this Senior Advisory Agreement or any of
your or the Company&rsquo;s respective obligations hereunder without the prior written consent of the other.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Miscellaneous</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">a)</TD><TD STYLE="text-align: justify">All notices and other communications hereunder shall
be in writing and shall be given by hand delivery to the other party, by registered or certified mail, return receipt requested,
postage prepaid, or by e-mail, read receipt requested, addressed as follows:</TD>
</TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0in">If to the Executive: at the address
and e-mail address on file in the Company&rsquo;s records</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0in">If to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0in">IDEXX Laboratories, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0in">One IDEXX Drive</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0in">Westbrook, ME 04092</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0in">Attention: General Counsel</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0in">E-mail: Sharon-Underberg@idexx.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0in">or to such other address as either
party shall have furnished to the other in writing in accordance herewith. Notice and communications shall be effective when actually
received by the addressee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">b)</TD><TD STYLE="text-align: left">No delay or omission by the Company in exercising any
right under this Senior Advisory Agreement shall operate as a waiver of that or any other right. A waiver or consent given by
the Company on any one occasion shall be effective only in that instance and shall not be construed as a bar or waiver of any
right on any other occasion.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">c)</TD><TD STYLE="text-align: left">The captions of the sections of this Senior Advisory
Agreement are for convenience of reference only and in no way define, limit or affect the scope or substance of any section of
this Senior Advisory Agreement.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">d)</TD><TD STYLE="text-align: left">In case any provision of this Senior Advisory Agreement
shall be invalid, illegal or otherwise unenforceable, the validity, legality and enforceability of the remaining provisions shall
in no way be affected or impaired thereby.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">e)</TD><TD STYLE="text-align: left">Nothing in this Senior Advisory Agreement precludes you
from providing truthful testimony when lawfully subpoenaed or otherwise required to do so by law.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">f)</TD><TD STYLE="text-align: left">This Senior Advisory Agreement may not be altered, amended
or modified except in writing signed by both the Company and you.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; text-align: center">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If any provision of this Senior Advisory Agreement shall be found by a court of competent jurisdiction to be invalid or
unenforceable, in whole or in part, then such provision shall be construed and/or modified or restricted to the extent and in the
manner necessary to render the same valid and enforceable, or shall be deemed excised from this Senior Advisory Agreement, as the
case may require, and this Senior Advisory Agreement shall be construed and enforced to the maximum extent permitted by law, as
if such provision had been originally incorporated herein as so modified or restricted, or as if such provision had not been originally
incorporated herein, as the case may be. The parties further agree to seek a lawful substitute for any provision found to be unlawful;
provided, that, if the parties are unable to agree upon a lawful substitute, the parties desire and request that a court or other
authority called upon to decide the enforceability of this Senior Advisory Agreement modify this Senior Advisory Agreement so that,
once modified, this Senior Advisory Agreement will be enforceable to the maximum extent permitted by the law in existence at the
time of the requested enforcement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Counterparts</U></B>.
This Senior Advisory Agreement may be executed in several counterparts, each of which shall be deemed to be an original, but all
of which together shall constitute one and the same instrument. Signatures delivered in .pdf format shall be deemed effective
for all purposes</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><I>[REMAINDER OF PAGE
INTENTIONALLY LEFT BLANK</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; text-align: center">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Please sign and return a counterpart of
this Senior Advisory Agreement to indicate your agreement with the terms and conditions contained herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: bottom; font-size: 10pt">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Very truly yours,</TD></TR>
<TR STYLE="vertical-align: bottom; font-size: 10pt">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-size: 10pt">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><B>IDEXX LABORATORIES, INC.</B></TD></TR>
<TR STYLE="vertical-align: bottom; font-size: 10pt">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-size: 10pt">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-size: 10pt">
    <TD STYLE="width: 50%; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid; width: 45%"><FONT STYLE="font-size: 10pt">/s/
    Giovani Twigge</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font-size: 10pt">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Giovani Twigge</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font-size: 10pt">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Corporate Vice President
    and Chief Human Resources Officer</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 220.5pt; text-indent: -40.5pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ACCEPTED AND AGREED AS OF THE DATE FIRST SET FORTH ABOVE:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: bottom; font-size: 10pt">
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">/s/ Jonathan W. Ayers</TD>
    <TD STYLE="width: 50%; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-size: 10pt">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Jonathan W. Ayers</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page - Ayers Advisory Agreement]</I></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; text-align: center">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>tm19207851_ex10-3.htm
<DESCRIPTION>EXHIBIT 10.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.3</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: right">Execution Copy<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECOND AMENDED AND RESTATED<BR>
EXECUTIVE EMPLOYMENT AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS SECOND AMENDED AND
RESTATED EMPLOYMENT AGREEMENT (this &ldquo;<U>Agreement</U>&rdquo;) is made as of October 23, 2019 (the &ldquo;<U>Effective Date</U>&rdquo;)
by and between IDEXX Laboratories, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), and Jonathan (Jay) Mazelsky
(the &ldquo;<U>Executive</U>&rdquo;) and amends and restates in its entirety the Amended and Restated Employment Agreement between
the Company and the Executive dated as of May 26, 2013.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Executive
previously served as the Executive Vice President of the Company and currently serves as the Interim President and Chief Executive
Officer of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company
desires to continue to employ the Executive as the President and Chief Executive Officer of the Company and wishes to acquire and
be assured of the Executive&rsquo;s services on the terms and conditions hereinafter set forth; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Executive
desires to continue to be employed by the Company as President and Chief Executive Officer and to perform and to serve the Company
on the terms and conditions hereinafter set forth.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in
consideration of the mutual covenants and promises contained in this Agreement and other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged by the parties to this Agreement, the Company and the Executive agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Employment Period</U>. The Company hereby agrees to continue the Executive in its employ, and the Executive hereby agrees
to remain in the employ of the Company, in each case, subject to the terms and conditions of this Agreement, for the period commencing
on the Effective Date, and ending on the date that the Executive&rsquo;s employment is terminated by either party to this Agreement
in accordance with Section 3 hereof (the &ldquo;<U>Employment Period</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Terms
of Employment</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Position
and Duties; Exclusivity</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>During the Employment Period, (A) the Executive shall serve as the Company&rsquo;s President and Chief Executive Officer,
and in such other positions as an officer or director of the Company and its affiliated companies as the Executive and the board
of directors of the Company (the &ldquo;<U>Board</U>&rdquo;) shall mutually agree from time to time, and shall report directly
to the Board. In the Executive&rsquo;s position as President and Chief Executive Officer, the Executive shall perform such duties,
functions and responsibilities during the Employment Period as are commensurate with such position, as reasonably and lawfully
directed by the Board. During the Employment Period, the Executive shall serve also as a member of the Board. The Executive&rsquo;s
principal place of employment shall be the Company&rsquo;s headquarters, which are currently in Westbrook, Maine. As used in this
Agreement, the term &ldquo;<U>affiliated companies</U>&rdquo; shall include any company controlled by, controlling or under common
control with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -1.5in; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -1.5in; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"> </P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -1.5in; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>During
the Employment Period, the Executive agrees to devote substantially all of the Executive&rsquo;s business time and attention to
the business and affairs of the Company and its affiliated companies, shall faithfully serve the Company, and shall conform to
and comply with the lawful and reasonable directions and instructions given to the Executive by the Board, consistent with Section
2(a)(i) hereof. During the Employment Period, the Executive shall use the Executive&rsquo;s best efforts to promote and serve
the interests of the Company and shall not engage in any other business activity, whether or not such activity shall be engaged
in for pecuniary profit; <U>provided</U> that the Executive may (A) serve any civic, charitable, educational or professional organization,
provided that such service is approved by the Chairman of the Board and the Chair of the Nominating and Governance Committee of
the Board (the &ldquo;<U>N&amp;G Committee</U>&rdquo;), (B) serve on the board of directors of one (1) for-profit business enterprise
(other than the Company), provided that such service is approved by the Chairman of the Board and the Chair of the N&amp;G Committee
and (C) manage the Executive&rsquo;s personal investments, in each case so long as any such activities do not (x) violate the
terms of this Agreement (including the terms of the Invention and Non-Disclosure Agreement attached as <U>Exhibit A </U>hereto
and the Non-Compete Agreement attached as <U>Exhibit B</U> hereto) or (y) interfere with the Executive&rsquo;s duties and responsibilities
to the Company. For this purpose, the &ldquo;<U>Chairman of the Board</U>&rdquo; shall mean the Board&rsquo;s lead independent
director, if any, or the Chair of the Board if he or she is an independent director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Compensation</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Base
Salary</U>. During the Employment Period, the Executive shall receive an annual base salary equal to $850,000 (the &ldquo;<U>Annual
Base Salary</U>&rdquo;), payable in accordance with the Company&rsquo;s standard payroll policies. During the Employment Period,
the Annual Base Salary shall be reviewed in the first quarter of the 2021 calendar year and thereafter at least annually. Any
increase in the Annual Base Salary shall not serve to limit or reduce any other obligation to the Executive under this Agreement.
The Annual Base Salary shall not be reduced after any such increase and, except as otherwise specified herein, the term the Annual
Base Salary as utilized in this Agreement shall refer to the Annual Base Salary as so increased.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Annual
Bonus</U>. In addition to Annual Base Salary, for each calendar year ending during the Employment Period, the Executive shall
be eligible to receive an annual bonus (the &ldquo;<U>Annual Bonus</U>&rdquo;) to be based upon Company performance and other
criteria for each such calendar year as may be determined by the Compensation Committee of the Board (the &ldquo;<U>Compensation
Committee</U>&rdquo;). The Executive&rsquo;s target Annual Bonus opportunity for the period beginning on the Effective Date through
December 2019 and for each calendar year that ends during the Employment Period thereafter shall equal 125% of the Annual Base
Salary in effect as of the end of such calendar year (the &ldquo;<U>Target Annual Bonus Opportunity</U>&rdquo;). The amount of
the Annual Bonus actually paid shall depend on the extent to which the performance goals, set annually by the Compensation Committee,
are achieved or exceeded, subject to a cap of 200% of the Target Annual Bonus Opportunity (unless otherwise determined by the
Compensation Committee in its discretion), and shall be subject to other such terms as determined by the Compensation Committee
in its discretion. The Annual Bonus shall be paid in cash no later than March 15 of the calendar year following the calendar year
in which such Annual Bonus is earned; <U>provided</U>, that, the Executive must be employed by the Company on the date of payment
to be entitled to receive an Annual Bonus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Incentive
Plans; Equity-Based Incentive Awards</U>. During the Employment Period, the Executive shall be entitled to participate in all
incentive plans, practices, policies and programs of the Company (including, but not limited to, the Company&rsquo;s 2018 Stock
Incentive Plan (the &ldquo;<U>2018 Stock Incentive Plan</U>&rdquo;) or any successor incentive plan adopted by the Company) to
the same extent as is applicable generally to other executive officers of the Company. In addition, (i) as soon as practicable
following the Effective Date, subject to approval by the Compensation Committee, the Executive shall be granted options to purchase
shares of common stock of the Company (&ldquo;<U>Options</U>&rdquo;) (x) with a grant date fair value of approximately $2,000,000,
and (y) an exercise price that is equal to 110% of the fair market value of one share of the common stock of the Company as of
the date of grant (the &ldquo;<U>Sign-On Equity Grant</U>&rdquo;), and (ii) in February 2020, subject to approval by the Compensation
Committee, the Executive shall be granted an additional equity-based incentive award (the &ldquo;<U>Additional Equity Grant</U>&rdquo;)
with a grant date fair value of approximately $4,000,000, to be determined and awarded on the same terms and conditions (including
the form and mix of award types) as those equity awards to be granted to other executive officers (unless otherwise determined
by the Compensation Committee) of the Company in February 2020, in each case, which terms and conditions will be determined by
the Compensation Committee. The Sign-On Equity Grant and the Additional Equity Grant will be granted under the 2018 Stock Incentive
Plan, and will be subject to the terms thereof, as well as of separate award agreements to be provided to the Executive under
separate cover.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Welfare Benefit, Savings and Retirement Plans</U>. During the Employment Period, the Executive and/or the Executive&rsquo;s
family, as the case may be, shall be eligible for participation in and shall receive all benefits under welfare benefit, savings
and retirement plans, practices, policies and programs provided by the Company to the extent applicable generally to other executive
officers of the Company, as may be in effect from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Reimbursement
of Business Expenses</U>. During the Employment Period, the Executive shall be entitled to receive reimbursement for all reasonable
expenses incurred by the Executive in accordance with the policies, practices and procedures of the Company in effect from time
to time. Any reimbursements made under this Agreement shall made or provided in accordance with Section 409A of the Internal Revenue
Code of 1986, as amended (the &ldquo;<U>Code</U>&rdquo;) to the extent that such reimbursements are subject to Section 409A, including,
as applicable, to the following conditions: (i) the amount of expenses eligible for reimbursement provided in any one taxable
year of Executive shall not affect the amount of expenses eligible for reimbursement or in-kind benefits provided in any other
taxable year of Executive, (ii) the reimbursement of any expense shall be made no later than the last day of Executive&rsquo;s
taxable year following Executive&rsquo;s taxable year in which the expense was incurred (unless this Agreement specifically provides
for reimbursement by an earlier date), and (iii) the right to reimbursement of an expense shall not be subject to set off, liquidation
or exchange for another benefit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>PTO</U>. During the Employment Period, the Executive shall be entitled to 26 days&rsquo; paid time off (&ldquo;<U>PTO</U>&rdquo;)
per calendar year in accordance with the plans, policies, programs and practices of the Company in effect from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Termination
of Employment</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Death or Disability</U>. The Executive&rsquo;s employment hereunder shall terminate automatically upon the Executive&rsquo;s
death during the Employment Period. If the Company determines in good faith that a Disability of the Executive has occurred during
the Employment Period (pursuant to the definition of Disability set forth below), it may provide to the Executive written notice
of its intention to terminate the Executive&rsquo;s employment. In such event, the Executive&rsquo;s employment with the Company
shall terminate effective on the thirtieth (30<SUP>th</SUP>) day after receipt of such notice by the Executive (the &ldquo;<U>Disability
Termination Date</U>&rdquo;); <U>provided</U>, that within the thirty (30) days after such receipt, the Executive shall not have
returned to full-time performance of the Executive&rsquo;s duties. For purposes of this Agreement, &ldquo;<U>Disability</U>&rdquo;
shall mean the Executive is unable to engage in any substantial gainful activity by reason of any medically determinable physical
or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than
twelve (12) months as determined by a physician selected by the Company or its insurers and acceptable to the Executive or the
Executive&rsquo;s legal representative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Cause</U>.
Subject to Section 3(d), the Company may terminate the Executive&rsquo;s employment during the Employment Period for Cause or
without Cause. For purposes of this Agreement, &ldquo;<U>Cause</U>&rdquo; shall mean any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
Executive&rsquo;s having engaged in willful misconduct or gross negligence in the performance of any of his duties to the Company,
which, if capable of being cured, is not cured to the reasonable satisfaction of the Board within thirty (30) days after the Executive
receives from the Board written notice of such willful misconduct or gross negligence;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
Executive&rsquo;s willful failure  or refusal to perform reasonably assigned directives of the Board or to cooperate with an
internal investigation being conducted by or at the direction of the Board which, if capable of being cured, is not cured to
the reasonable satisfaction of the Board within thirty (30) days after the Executive receives from the Board written notice
of such failure or refusal;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>any
indictment of the Executive for, any conviction of the Executive of, or plea of guilty or nolo contendere by the Executive to,
(x) any felony or (y) any crime (whether or not a felony) involving fraud, theft, breach of trust or similar acts, in any case,
whether under the laws of the United States or any state thereof or any foreign law to which the Executive may be subject;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
Executive&rsquo;s willful or continued failure to comply with any written rules, regulations, policies or procedures of the
Company which, if not complied with, would reasonably be expected to have a material adverse effect on the business,
financial condition or reputation of the Company, as determined by the Company in its reasonable discretion, which in the
case of a failure that is capable of being cured, is not cured to the reasonable satisfaction of the Board within thirty (30)
days after the Executive receives from the Company written notice of such failure; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
Executive&rsquo;s abuse of alcohol or another controlled substance that would reasonably be expected to result in a material adverse
effect on the business, financial condition or reputation of the Company, as determined by the Company in its reasonable discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Good
Reason</U>. Subject to Section 3(d), the Executive&rsquo;s employment may be terminated by the Executive during the Change of
Control Period (as defined below) with Good Reason, or any time during the Employment Period (whether or not during the Change
of Control Period) without Good Reason. For purposes of this Agreement, &ldquo;<U>Good Reason</U>&rdquo; shall mean one or more
of the following conditions arising without the consent of the Executive during the Change of Control Period:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>A material diminution in the Executive&rsquo;s Annual Base Salary or Annual Bonus opportunity;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>A
material diminution in the Executive&rsquo;s authority, duties, or responsibilities; <U>provided</U> that, for the avoidance of
doubt, if at any time, (x) the Executive ceases to be the President and Chief Executive Officer of the Company, the entity surviving
any Business Combination (as defined below) (if not the Company), or the Person that ultimately controls the Company or such surviving
entity, or (y) if the Executive is required to report to a corporate officer or employee instead of reporting directly to the
Board of Directors of the Company, then, in each case, a material diminution of the Executive&rsquo;s authority, duties, or responsibilities
shall be deemed to have occurred;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>A
material diminution in the budget over which the Executive retains authority;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>A
material change in the geographic location at which the Executive must perform services; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Any other action or inaction that constitutes a material breach by the Company of the agreement under which the Executive
provides services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Notice
of Termination</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Company may terminate the Executive&rsquo;s employment hereunder other than for Cause, or due to Disability during the Employment
Period at any time upon not less than thirty (30) days&rsquo; written notice, and the Executive may terminate his employment hereunder
for any reason during the Employment Period at any time upon not less than sixty (60) days&rsquo; written notice. The Company
may terminate the Executive&rsquo;s employment hereunder for Cause at any time. Any termination by the Company (either for Cause
or other than for Cause), or by the Executive for any reason (including for Good Reason), shall be effected by Notice of Termination
being provided to the other party hereto. For purposes of this Agreement, a &ldquo;<U>Notice of Termination</U>&rdquo; means a
written notice which (i) indicates the specific termination provision in this Agreement relied upon, (ii) to the extent applicable,
sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Executive&rsquo;s
employment under the provision so indicated, and (iii) if the Date of Termination (as defined below) is other than the date of
receipt of such notice, specifies the termination date (which date shall be not more than thirty days after the giving of such
notice). The failure by the Executive or the Company to set forth in the Notice of Termination any fact or circumstance which
contributes to a showing of Good Reason or Cause, as applicable, shall not waive any right of the Executive or the Company, respectively,
hereunder or preclude the Executive or the Company, respectively, from asserting such fact or circumstances in enforcing the Executive&rsquo;s
or the Company&rsquo;s rights hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Prior to any termination for Cause becoming effective, the Executive shall be entitled to a hearing before the Board at
which he may, at his election, be represented by counsel and at which he shall have a reasonable opportunity to be heard. Such
hearing shall be held on not less than fifteen (15) days&rsquo; prior written notice to the Executive stating the Board&rsquo;s
intention to terminate the Executive for Cause and stating in detail the particular event(s) or circumstance(s) which the Board
believes constitute(s) Cause for termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Any Notice of Termination for Good Reason must be given to the Company within sixty (60) days of the initial existence of
one or more conditions described in Section 3(c)(i) through (v) which the Executive believes constitute(s) Good Reason. In the
event that the Executive provides the Company with a Notice of Termination for Good Reason, the Company shall be entitled to a
period of thirty (30) days during which it may remedy the condition(s) described in Section 3(c)(i) through (v) giving rise to
the alleged Good Reason. Failing such remedy, a termination of employment by the Executive for Good Reason shall be effective on
the day following the expiration of such thirty (30) day period. It is intended that termination of employment by an Executive
due to one or more of the conditions described in Section 3(c)(i) through (v), pursuant to notice given in accordance with this
Section 3(d)(iii), shall be treated as an involuntary separation from service pursuant to the good reason safe harbor set forth
in Treasury Regulation Section 1.409A-1(n)(2)(ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Date
of Termination</U>. &ldquo;<U>Date of Termination</U>&rdquo; means (i) if the Executive&rsquo;s employment is terminated by the
Company for Cause, the date of the Executive&rsquo;s receipt of the Notice of Termination or any later date specified by the Company,
as the case may be; <U>provided</U>, that this date may be delayed in order to ensure the Company&rsquo;s compliance with Section
3(d)(ii); (ii) if the Executive&rsquo;s employment terminated by the Executive for Good Reason, subject to the Executive&rsquo;s
compliance with Section 3(d)(iii) and the Company&rsquo;s failure to cure as set forth in Section 3(d)(iii), the date of the expiration
of the cure period; (iii) if the Executive&rsquo;s employment is terminated by the Executive other than for Good Reason, the sixtieth
(60<SUP>th</SUP>) day following the Company&rsquo;s receipt of the Executive&rsquo;s Notice of Termination, or any earlier or
later date as shall be agreed by the Company; (iv) if the Executive&rsquo;s employment is terminated by the Company other than
for Cause or by reason of Disability or death, the thirtieth (30<SUP>th</SUP>) day following the Executive&rsquo;s receipt of
the Notice of Termination or any later date specified by the Company; and (v) if the Executive&rsquo;s employment is terminated
by reason of death or Disability, the Date of Termination shall be the date of death of the Executive or the Disability Termination
Date, as the case may be. Whether a Participant has had a termination of employment shall be determined by the Company on the
basis of all relevant facts and circumstances with reference to Treasury Regulations Section 1.409A-1(h) regarding a &ldquo;separation
from service&rdquo; and the default provisions set forth in Treasury Regulation Section 1.409A-1(h)(1)(ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Obligations of the Company Upon Termination</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Other
Than for Cause</U>. If, during the Employment Period, the Company shall terminate the Executive&rsquo;s employment other
than for Cause (other than a termination upon a Change of Control or during the Change of Control Period (each, as defined
below), in each case, which shall be subject to Section 5(c) below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the Company shall pay to the Executive in a lump sum in cash the following amounts: the sum of (1) the Executive&rsquo;s
Annual Base Salary through the Date of Termination to the extent not theretofore paid, (2) any unused PTO paid out at the per-business-day
Annual Base Salary rate, (3) any additional vested benefits in accordance with the applicable terms of applicable Company arrangements,
and (4) any unreimbursed expenses in accordance with Section 2(b)(v), the sum of the amounts described in clauses (1), (2), (3)
and (4) shall be hereinafter referred to as the &ldquo;<U>Accrued Obligations</U>&rdquo;); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>subject,
in each case, to Sections 11 and 12 hereof and the Executive&rsquo;s continued compliance with the covenants and obligations set
forth in the Invention and Non-Disclosure Agreement attached hereto as <U>Exhibit A</U>, and the Non-Compete Agreement attached
hereto as <U>Exhibit B</U>, the Company shall provide the Executive with:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">A.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>payment
equal to the product of (x) two, <I>multiplied by </I>(y) the Executive&rsquo;s Annual Base Salary, payable ratably over the twenty-four
(24) month period following the Date of Termination (the &ldquo;<U>Severance Period</U>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">B.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>subject to the Executive&rsquo;s timely election of continuation coverage under the Consolidated Omnibus Budget Reconciliation
Act of 1985, as amended (&ldquo;<U>COBRA</U>&rdquo;), a lump sum cash payment in an amount equal to the employer portion of the
costs of continued health benefits for the Executive and his covered dependents (based on the level of coverage in effect as of
the Date of Termination) (the &ldquo;<U>Health Benefits Payment</U>&rdquo;) for the twenty-four (24) month period following the
Date of Termination; <U>provided</U>, <U>however</U>, that if the Company&rsquo;s provision of the Health Benefits Payment to the
Executive under this Section 4(a)(i)(B) would violate the nondiscrimination rules applicable to health plans or self-insured plans
under Section 105(h) of the Code, or result in the imposition of penalties under the Patient Protection and Affordable Care Act
of 2010 and the related regulations and guidance promulgated thereunder (the &ldquo;<U>PPACA</U>&rdquo;), the parties agree to
reform this Section 4(a)(i)(B) in a manner as is necessary to comply with the PPACA and the Code; <U>provided</U>, <U>further</U>,
that nothing herein provided shall be construed to extend the period of time over which COBRA continuation coverage otherwise may
be provided to you and/or your dependents in accordance with applicable law; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">C.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>for purposes of any equity incentive awards granted to the Executive that remain outstanding on the Date of Termination,
and notwithstanding anything to the contrary in the applicable award agreement, the 2018 Stock Incentive Plan (or any predecessor
or successor equity compensation plan), or elsewhere, such equity incentive awards that would otherwise be scheduled to vest during
the Severance Period shall continue to vest during such period in accordance with the vesting schedule in effect prior to the Date
of Termination. In addition (i) any Options that were vested immediately prior to the Date of Termination shall be exercisable
for (x) ninety (90) days following the Date of Termination, or (y) twenty-four (24) months following the date of termination if
the Executive is &ldquo;Retirement&rdquo;-eligible (as defined in the applicable award agreement governing the Options) as of the
Date of Termination, and (ii) any Options that vest during the Severance Period pursuant to the foregoing sentence shall be exercisable
for ninety (90) days following the conclusion of the Severance Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<!-- Field: Page; Sequence: 7; Value: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Death</U>.
If the Executive&rsquo;s employment is terminated by reason of the Executive&rsquo;s death during the Employment Period, this
Agreement shall terminate without further obligations to the Executive&rsquo;s legal representatives under this Agreement, other
than for payment of Accrued Obligations to the Executive&rsquo;s estate or beneficiary, as applicable, in a lump sum in cash within
thirty (30) days of the Date of Termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Disability</U>. If the Executive&rsquo;s employment is terminated by reason of the Executive&rsquo;s Disability during
the Employment Period, this Agreement shall terminate without further obligations to the Executive, other than for payment of Accrued
Obligations to the Executive in a lump sum in cash within thirty (30) days of the Date of Termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Cause;
Other than for Good Reason</U>. If the Executive&rsquo;s employment shall be terminated by the Company for Cause during the Employment
Period, this Agreement shall terminate without further obligations to the Executive other than the obligation to pay to the Executive
the Accrued Obligations. If the Executive voluntarily terminates employment during the Employment Period, excluding a termination
for Good Reason during the Change of Control Period, this Agreement shall terminate without further obligations to the Executive,
other than the obligation to pay to the Executive the Accrued Obligations. In such cases, all Accrued Obligations shall be paid
to the Executive in a lump sum in cash within thirty (30) days of the Date of Termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Time
of Payment</U>. Amounts payable under this Section 4 following an Executive&rsquo;s termination of employment, other than those
expressly payable on a deferred basis, will be paid in the payroll period next following the payroll period in which termination
of employment occurs except as otherwise provided in Sections 11 or 12.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Change
of Control</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Change
of Control Defined</U>. For the purpose of this Agreement, a &ldquo;Change of Control&rdquo; shall mean:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
acquisition by an individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act
of 1934, as amended (the &ldquo;<U>Exchange Act</U>&rdquo;)) (a &ldquo;<U>Person</U>&rdquo;) of beneficial ownership (within the
meaning of Rule 13d-3 promulgated under the Exchange Act) of 35% or more of either (x) the then-outstanding shares of common stock
of the Company (the &ldquo;<U>Outstanding Company Common Stock</U>&rdquo;) or (y) the combined voting power of the then-outstanding
voting securities of the Company entitled to vote generally in the election of directors (the &ldquo;<U>Outstanding Company Voting
Securities</U>&rdquo;); provided, however, that for purposes of this subsection (i), the following acquisitions shall not constitute
a Change of Control: (a) any acquisition directly from the Company, (b) any acquisition by the Company, (c) any acquisition by
any employee benefit plan (or related trust) sponsored or maintained by the Company or any corporation controlled by the Company,
or (d) any acquisition by any corporation pursuant to a transaction which satisfies the criteria set forth in clauses (x), (y)
and (z) of subsection (iii) of this Section 5(a); or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>A
change in the composition of the Board, as a result of which fewer than one-half of the incumbent directors are directors who
either (x) had been directors of the Company 24 months prior to such change or (y) were elected, or nominated for election, to
the Board with the affirmative votes of at least a majority of the directors who had been directors of the Company 24 months prior
to such change and who were still in office at the time of the election or nomination; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Consummation of a reorganization, merger or consolidation or sale or other disposition of all or substantially all of the
assets of the Company (a &ldquo;<U>Business Combination</U>&rdquo;), in each case, unless, immediately following such Business
Combination, (x) all or substantially all of the individuals and entities who were the beneficial owners, respectively, of the
Outstanding Company Common Stock and Outstanding Company Voting Securities immediately prior to such Business Combination beneficially
own, directly or indirectly, more than a majority of, respectively, the then-outstanding shares of common stock and the combined
voting power of the then-outstanding voting securities entitled to vote generally in the election of directors, of the corporation
resulting from such Business Combination (which as used in this Section 5(a)(iii) shall include, without limitation, a corporation
which as a result of such transaction owns the Company or all or substantially all of the Company&rsquo;s assets either directly
or through one or more subsidiaries) in substantially the same proportions as their ownership, immediately prior to such Business
Combination of the Outstanding Company Common Stock and Outstanding Company Voting Securities, as the case may be, (y) no Person
(excluding any corporation resulting from such Business Combination or any employee benefit plan (or related trust) of the Company
or such corporation resulting from such Business Combination) beneficially owns, directly or indirectly, 20% or more of, respectively,
the then outstanding shares of common stock of the corporation resulting from such Business Combination, or the combined voting
power of the then-outstanding voting securities of such corporation and (z) at least half of the members of the board of directors
of the corporation resulting from such Business Combination were members of the Company&rsquo;s Board at the time of the execution
of the initial agreement, or of the action of the Board, providing for such Business Combination; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Approval
by the shareholders of the Company of a complete liquidation or dissolution of the Company or the consummation of a sale of all
or substantially all of the assets of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in; text-align: justify">Notwithstanding the foregoing, for any payments
or benefits hereunder that are subject to Section 409A of the Code, the foregoing event must constitute a &ldquo;change in control
event&rdquo; within the meaning of Treasury Regulation Section 1.409A-3(i)(5)(i).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Treatment
of Equity Upon a Change of Control</U>. Notwithstanding anything to the contrary in the applicable award agreement, the 2018 Stock
Incentive Plan (or any predecessor or successor equity compensation plan), or elsewhere, immediately prior to the consummation
of a Change of Control, each then outstanding unvested equity-based incentive award in the Company held by the Executive shall
become immediately vested (and fully exercisable, as applicable) with respect to twenty-five percent (25%) of the number of shares
of common stock of the Company covered by such equity-based incentive award (rounded down to the nearest whole share).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9; Value: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Obligations
of the Company Upon Termination for Good Reason or Other Than for Cause During the Change of Control Period</U>. If the Company
shall terminate the Executive&rsquo;s employment other than for Cause or the Executive shall terminate his employment for Good
Reason, in each case either upon a Change of Control or within twenty-four (24) months following a Change of Control (the &ldquo;<U>Change
of Control Period</U>&rdquo;):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
Company shall pay to the Executive the Accrued Obligations in a lump sum; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>subject,
in each case, to Sections 11 and 12 hereof, the Company shall provide the Executive with a lump sum payment in cash consisting
of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">A.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the amount equal to the product of (x) three, <I>multiplied by </I>(y) the sum of (i) the Annual Base Salary, <I>plus </I>(ii)
the Average Annual Bonus. The &ldquo;<U>Average Annual Bonus</U>&rdquo; shall be equal to the average of the Annual Bonus paid
(or payable) to the Executive for the three (3) prior full calendar years (or, if fewer, the number of full calendar years the
Executive was employed by the Company prior to the Date of Termination); <U>provided</U> that if the Executive was not eligible
to receive an Annual Bonus for at least one (1) full calendar year during the Employment Term, the Average Annual Bonus shall be
the Executive&rsquo;s Target Annual Bonus for the year in which termination of employment occurs;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">B.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
Health Benefits Payment, to cover the employer portion of the costs for the thirty-six (36) month period following the Date of
Termination; <U>provided</U>, <U>however</U>, that if the Company&rsquo;s provision of the Health Benefits Payment to the Executive
under this Section 5(c)(ii)(B) would violate the nondiscrimination rules applicable to health plans or self-insured plans under
Section 105(h) of the Code, or result in the imposition of penalties under the PPACA, the parties agree to reform this Section
5(c)(ii)(B) in a manner as is necessary to comply with the PPACA and the Code; <U>provided</U>, <U>further</U>, that nothing herein
provided shall be construed to extend the period of time over which COBRA continuation coverage otherwise may be provided to you
and/or your dependents in accordance with applicable law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">C.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>notwithstanding
anything to the contrary in the applicable award agreement, the 2018 Stock Incentive Plan (or any predecessor or successor equity
compensation plan), or elsewhere, the immediate vesting (and full exercisability, as applicable) of all then-outstanding unvested
equity-based incentive awards in the Company held by the Executive; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">D.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
Company shall timely reimburse the Executive up to $12,500 each year (an aggregate of $25,000) for expenses incurred in connection
with outplacement services and relocation costs incurred in connection with obtaining new employment outside the State of Maine
until the earlier of (i) twenty-four (24) months following termination of the Executive&rsquo;s employment; or (ii) the date the
Executive secures full time employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Time
of Payment</U>. Amounts payable under Section 5(c) following an Executive&rsquo;s termination of employment will be paid in the
payroll period next following the payroll period in which termination of employment occurs except as otherwise provided in Sections
11 or 12.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10; Value: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Resignation
of all Positions</U>. Upon and following the termination of the Executive&rsquo;s employment with the Company for any
reason, if at any time the Board determines in its sole discretion to request that the Executive step down from the his role
as a director of the Company and no longer serve in such capacity, the Executive shall promptly tender such resignation as a
director of the Company, and if the Executive fails to tender such resignation on a timely basis, the Executive shall be
deemed to have resigned, as of the Termination Date. In addition, upon the termination of the Executive&rsquo;s employment
with the Company for any reason and except as expressly set forth above, the Executive shall resign, as of the Termination
Date, from all positions the Executive then holds as an officer, director, employee and member of the boards of directors
(and any committee thereof) of the Company and its subsidiaries and affiliates. The Executive shall be required to execute
such writings as are required, in the sole discretion of the Company, to effectuate the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Nonexclusivity
of Rights</U>. Nothing in this Agreement shall prevent or limit the Executive&rsquo;s continuing or future participation in any
plan, program, policy or practice provided by the Company or any of its affiliated companies and for which the Executive may qualify,
nor, subject to Section 12(f), shall anything herein limit or otherwise affect such rights as the Executive may have under any
contract or agreement with the Company or any of its affiliated companies. Amounts which are vested benefits or which the Executive
is otherwise entitled to receive under any plan, policy, practice or program of or any contract or agreement with the Company
or any of its affiliated companies at or subsequent to the Date of Termination shall be payable in accordance with such plan,
policy, practice or program or contract or agreement except as explicitly modified by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Full Settlement</U>. In the event of the termination of the Executive&rsquo;s employment upon a Change of Control or
during the Change of Control Period (other than a termination by the Company for Cause), the Company&rsquo;s obligation to make
the payments provided for in this Agreement and otherwise to perform its obligations hereunder shall not be affected by any set-off,
counterclaim, recoupment, defense or other claim, right or action which the Company may have against the Executive (under this
Agreement or otherwise) or others. Regardless of the reason for or timing of the Executive&rsquo;s termination of employment (whether
prior to or upon a Change of Control or during or following the Change of Control Period), the Executive shall in no event be obligated
to seek other employment or take any other action by way of mitigation of the amounts payable to the Executive under any of the
provisions of this Agreement and, except as otherwise provided in this agreement, such amounts shall not be reduced whether or
not the Executive obtains other employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Confidential Information; Restrictive Covenants</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Executive shall hold in a fiduciary capacity for the benefit of the Company all secret or confidential information,
knowledge or data relating to the Company or any of its affiliated companies, and their respective businesses, which shall
have been obtained by the Executive during the Executive&rsquo;s employment by the Company or any of its affiliated companies
and which shall not be or become public knowledge (other than by acts by the Executive or representatives of the Executive in
violation of this Agreement). After termination of the Executive&rsquo;s employment with the Company, the Executive shall
not, without the prior written consent of the Company or as may otherwise be required by law or legal process, communicate or
divulge any such information, knowledge or data to anyone other than the Company and those designated by it. The Executive
agrees that any breach of the terms of this Section 9 or the Invention and Non-Disclosure Agreement attached hereto as <U>Exhibit
A</U>, and the Non-Compete Agreement attached hereto as <U>Exhibit B</U> would result in irreparable injury and damage to the
Company for which the Company would have no adequate remedy at law. The Executive therefore also agrees that in the event of
said breach or any threat of breach, the Company shall be entitled to an immediate injunction and restraining order to
prevent such breach and/or threatened breach and/or continued breach by the Executive and/or any and all Persons acting for
and/or with the Executive, without having to prove damages, in addition to any other remedies to which the Company may be
entitled at law or in equity, including, without limitation, the obligation of the Executive to return any portion of the
severance payments and benefits set forth in Sections 4(a)(ii) or 5(c)(ii), as applicable, paid by the Company to the
Executive. The terms of this Section 9(a) shall not prevent the Company from pursuing any other available remedies for any
breach or threatened breach hereof, including, without limitation, the recovery of damages from the Executive. The Executive
and the Company further agree that the provisions of the covenants contained in this Section 9 and the Invention and
Non-Disclosure Agreement attached hereto as <U>Exhibit A</U>, and the Non-Compete Agreement attached hereto as <U>Exhibit
B</U> are, in each case, reasonable and necessary to protect the businesses of the Company and its affiliated companies
because of the Executive&rsquo;s access to confidential information and the Executive&rsquo;s material participation in the
operation of such businesses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Simultaneously
with the execution of this Agreement, the Executive shall execute the Invention and Non-Disclosure Agreement attached hereto as
<U>Exhibit A</U>, and the Non-Compete Agreement attached hereto as <U>Exhibit B</U>, which shall be deemed to be incorporated
by reference into this Agreement, and effective as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>From
and after the Effective Date, including at all times following the Date of Termination, (i) the Executive agrees not to make any
statement that is intended to become public, or that should reasonably be expected to become public, and that criticizes, ridicules,
disparages or is otherwise derogatory of the Company, any of its affiliated companies, or their respective employees, officers,
directors or stockholders, and (ii) the Company shall direct its officers, directors, and other authorized representatives not
to make any statement that is intended to become public, or that should reasonably be expected to become public, and that criticizes,
ridicules, disparages or is otherwise derogatory of the Executive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Successors</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>This
Agreement is personal to the Executive and without the prior written consent of the Company shall not be assignable by the Executive
otherwise than by will or the laws of descent and distribution. This Agreement shall inure to the benefit of and be enforceable
by the Executive&rsquo;s legal representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>This
Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Company will require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially
all of the business and/or assets of the Company to assume expressly and agree to perform this Agreement in the same manner and
to the same extent that the Company would be required to perform it if no such succession had taken place. As used in this Agreement,
 &ldquo;<U>Company</U>&rdquo; shall mean the Company as hereinbefore defined and any successor to its business and/or assets as
aforesaid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12; Value: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Section
409A Compliance</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>It is intended that each payment or benefit or installment of payments and benefits under this Agreement shall be treated
as a &ldquo;separate payment&rdquo; for purposes of Section 409A of the Code. Neither the Company nor the Executive shall have
the right to accelerate or defer the delivery of any payments or benefits except to the extent specifically permitted or required
by Section 409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>If any payment, compensation or other benefit provided to the Executive in connection with his employment termination is
determined, in whole or in part, to constitute &ldquo;nonqualified deferred compensation&rdquo; within the meaning of Section 409A
of the Code and the Executive is a Specified Employee as defined in Section 409A(a)(2)(B)(i), no part of such payments shall be
paid before the day that is six (6) months plus one (1) day after the date of termination, or, if earlier, the Executive&rsquo;s
death (the &ldquo;<U>New Payment Date</U>&rdquo;). The aggregate of any payments that otherwise would have been paid to the Executive
during the period between the date of termination and the New Payment Date shall be paid to the Executive in a lump sum on such
New Payment Date. Thereafter, any payments that remain outstanding as of the day immediately following the New Payment Date shall
be paid without delay over the time period originally scheduled, in accordance with the terms of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>For purposes of this Agreement, a &ldquo;<U>Specified Employee</U>&rdquo; shall mean an employee of the Company who satisfies
the requirements for being designated a &ldquo;key employee&rdquo; under Section 416(i)(1)(A)(i), (ii) or (iii) of the Code without
regard to Section 416(i)(5) of the Code at any time during a calendar year, in which case such employee shall be considered a Specified
Employee for the twelve-month period beginning on the first day of the fourth month immediately following the end of such calendar
year. Notwithstanding the foregoing, all employees who are nonresident aliens during an entire calendar year are excluded for purposes
of determining which employees meet the requirements of Section 416(i)(1)(A)(i), (ii) or (iii) of the Code without regard to Section
416(i)(5) of the Code for such calendar year. The term &ldquo;nonresident alien&rdquo; as used herein shall have the meaning set
forth in Regulations Section 1.409A-1(j). In the event of any corporate spinoff or merger, the determination of which employees
meet the requirements of Section 416(i)(1)(A)(i), (ii) or (iii) of the Code without regard to Section 416(i)(5) of the Code for
any calendar year shall be determined in accordance with Regulations Section 1.409A-1(i)(6).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
terms of this Agreement are intended to comply with or be exempt from Section 409A of the Code and the guidance issued thereunder
and shall be interpreted consistently therewith. The parties acknowledge and agree that the interpretation of Section 409A and
its application to the terms of this Agreement is uncertain and may be subject to change as additional guidance and interpretations
become available. Anything to the contrary herein notwithstanding, all benefits or payments provided by the Company to the Executive
that would be deemed to constitute &ldquo;nonqualified deferred compensation&rdquo; within the meaning of Section&nbsp;409A are
intended to comply with Section 409A. If, however, any such benefit or payment is deemed to not comply with Section 409A, the
Company and the Executive agree to renegotiate in good faith any such benefit or payment (including, without limitation, as to
the timing of any severance payments payable hereunder) so that either (i) Section 409A will not apply or (ii) compliance with
Section 409A will be achieved; <U>provided</U>, <U>however</U>, that any resulting renegotiated terms shall provide to the Executive
the after-tax economic equivalent of what otherwise has been provided to the Executive pursuant to the terms of this Agreement,
and <U>provided</U>&nbsp;<U>further</U>, that any deferral of payments or other benefits shall be only for such time period as
may be required to comply with Section 409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Value: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Release</U>.
As a condition of receipt of the severance payments and benefits set forth in Sections 4(a)(ii) or 5(c)(ii) of this Agreement,
as applicable, the Executive shall be required to sign a release of claims in substantially the form attached hereto as <U>Exhibit
C</U> (the &ldquo;<U>Release</U>&rdquo;) and to abide by the provisions thereof. The Release contains a release and waiver of
any claims the Executive or his or her representatives may have against the Company, any of its affiliated companies, and any
of their respective officers, directors, affiliates and/or representatives, and shall release those entities and persons from
any liability for such claims including, but not limited to, all employment discrimination claims. Payments and benefits under
this Agreement will be paid on the sixtieth (60<SUP>th</SUP>) day following the Executive&rsquo;s termination of employment provided
the Executive has executed and submitted the Release and the statutory period during which the Executive is entitled to revoke
the Release has expired on or before that sixtieth (60<SUP>th</SUP>) day. If the Executive fails to so execute or revokes the
Release, the Executive will not be entitled to receive any of the severance payments or benefits, the receipt of which is made
contingent upon such execution and non-revocation, as set forth in Sections 4(a)(ii) and 5(c)(ii) hereof, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">13.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>This
Agreement shall be governed by and construed in accordance with the laws of the State of Maine, without reference to principles
of conflict of laws. The captions of this Agreement are not part of the provisions hereof and shall have no force or effect. This
Agreement may not be amended or modified otherwise than by a written agreement executed by the parties hereto or their respective
successors and legal representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>All
notices and other communications hereunder shall be in writing and shall be given by hand delivery to the other party, by registered
or certified mail, return receipt requested, postage prepaid, or by e-mail, read receipt requested, addressed as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 14; Value: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify">If to the Executive:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify">at the address and e-mail address
on file in the Company&rsquo;s records</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify">If to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify">IDEXX Laboratories, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify">One Idexx Drive</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify">Westbrook, ME 04092</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify">Attention: Corporate Vice President
and Chief Human Resources Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify">E-mail: Gio-Twigge@idexx.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">or to such other address as either party
shall have furnished to the other in writing in accordance herewith. Notice and communications shall be effective when actually
received by the addressee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of
any other provision of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Company may withhold from any amounts payable under this Agreement such Federal, state, local or foreign taxes as shall be required
to be withheld pursuant to any applicable law or regulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Executive&rsquo;s or the Company&rsquo;s failure to insist upon strict compliance with any provision of this Agreement or the
failure to assert any right the Executive or the Company may have hereunder, including without limitation, the right of the Executive
to terminate employment for Good Reason pursuant to Section 3(c) of this Agreement, shall not be deemed to be a waiver of such
provision or right or any other provision or right of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Executive and the Company acknowledge that, except as may otherwise be provided under any other written agreement between the
Executive and the Company, the employment of the Executive by the Company is &ldquo;at-will&rdquo; and the Executive&rsquo;s employment
and/or this Agreement may be terminated by either the Executive or the Company by written notice to the other, at any time, in
which case the Executive shall have no further rights or obligations under this Agreement (other than those set forth in Section
4 and Section 5(c), as applicable). From and after the Effective Date this Agreement shall supersede any other agreement between
the parties with respect to the subject matter hereof, including, but not limited to, that certain Amended and Restated Executive
Employment Agreement by and between the Company and the Executive, dated as of May 26, 2013 and that certain Executive Employment
Agreement by and between the Company and the Executive dated as of February 13, 2012 (and the Invention and Non-Disclosure Agreement
and Non-Compete Agreement attached thereto, respectively) and supersedes all prior communications, agreements and understandings,
written or oral, with the Company or any of its affiliates or predecessors with respect to the terms and conditions of the Executive&rsquo;s
employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 15; Value: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Executive agrees that jurisdiction and venue for any action arising from or relating to this Agreement or the relationship between
the parties, including but not limited to matters concerning validity, construction, performance, or enforcement, shall be exclusively
in the federal and state courts of the State of Maine located in Cumberland County (collectively, the &ldquo;<U>Selected Courts</U>&rdquo;)
(provided, that a final judgment in any such action shall be conclusive and enforced in other jurisdictions) and further agree
that service of process may be made in any manner permitted by law. The Executive irrevocably waives and agrees not to assert
(i) any objection which it may ever have to the laying of venue of any action or proceeding arising out of this Agreement or the
transactions contemplated hereby in the Selected Courts, and (ii) any claim that any such action brought in any such court has
been brought in an inconvenient forum. This Section 13(g) is intended to fix the location of potential litigation between the
parties and does not create any causes of action or waive any defenses or immunities to suit, or obviate the rights of the parties
to agree to arbitration with respect to any conflicts related to this Agreement or the Executive&rsquo;s employment hereunder.
EACH PARTY WAIVES ANY RIGHT TO A TRIAL BY JURY, TO THE EXTENT LAWFUL, AND AGREES THAT ANY OF THEM MAY FILE A COPY OF THIS PARAGRAPH
WITH ANY COURT AS WRITTEN EVIDENCE OF THE KNOWING, VOLUNTARY AND BARGAINED-FOR AGREEMENT AMONG THE PARTIES IRREVOCABLY TO WAIVE
ITS RIGHT TO TRIAL BY JURY IN ANY LITIGATION WHATSOEVER BETWEEN THEM RELATING TO THIS AGREEMENT OR THE CONTEMPLATED TRANSACTIONS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Whenever
possible, each provision or portion of any provision of this Agreement, including those contained in the Invention and Non-Disclosure
Agreement attached hereto as <U>Exhibit A</U>, and the Non-Compete Agreement attached hereto as <U>Exhibit B</U>, will be interpreted
in such manner as to be effective and valid under applicable law but the invalidity or unenforceability of any provision or portion
of any provision of this Agreement in any jurisdiction shall not affect the validity or enforceability of the remainder of this
Agreement in that jurisdiction or the validity or enforceability of this Agreement, including that provision or portion of any
provision, in any other jurisdiction. In addition, should a court or arbitrator determine that any provision or portion of any
provision of this Agreement, including those contained in the Invention and Non-Disclosure Agreement attached hereto as <U>Exhibit
A</U>, and the Non-Compete Agreement attached hereto as <U>Exhibit B</U>, is not reasonable or valid, either in period of time,
geographical area, or otherwise, the parties hereto agree that such provision should be interpreted and enforced to the maximum
extent which such court or arbitrator deems reasonable or valid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>This
Agreement may be executed by .pdf or facsimile signatures in any number of counterparts, each of which shall be deemed an original,
but all such counterparts shall together constitute one and the same instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Remainder of Page Intentionally Left Blank]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 16; Value: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the
Executive has hereunto set the Executive&rsquo;s hand and, pursuant to the authorization from its Board of Directors, the Company
has caused these presents to be executed in its name on its behalf, all as of the day and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">EXECUTIVE:</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">/s/
Jonathan (Jay) Mazelsky</FONT></P></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Jonathan (Jay) Mazelsky</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">COMPANY:</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">IDEXX Laboratories, Inc.</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Giovani Twigge </FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name: Giovani Twigge</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title: Corporate Vice President and Chief
    Human Resources Officer</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 211.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 211.5pt"></P>

<!-- Field: Page; Sequence: 17; Value: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 211.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Exhibit A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 24%; font-size: 10pt; text-align: left; padding-left: 0.25in"><FONT STYLE="font-size: 10pt"><IMG SRC="tm19207851_ex10-3img01.jpg" ALT=""></FONT></TD>
    <TD STYLE="width: 76%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt; color: black">Invention and Non-Disclosure
    Agreement</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 13pt Times New Roman, Times, Serif; margin: 0pt 1.1in 0pt 0.3in"><FONT STYLE="font-size: 10pt">I, Jonathan (<FONT STYLE="color: #1B1B1B">Jay)
Mazelsky, </FONT>hereby agree as follows:</FONT></P>

<P STYLE="font: 13pt Times New Roman, Times, Serif; margin: 0pt 1.1in 0pt 0.3in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15in; text-align: justify">1. <B>Inventions and Patents</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15in; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.3in"></TD><TD STYLE="width: 0.3in">(a)</TD><TD STYLE="text-align: justify">I will promptly and fully disclose to IDEXX Laboratories, Inc. (together with its subsidiaries
and affiliates, the &ldquo;Company&rdquo;) any and all inventions, discoveries, trade secrets and improvements, whether or not
patentable or whether or not they are made, conceived or reduced to practice during working hours or using the Company&rsquo;s
data or facilities, which I have developed, made, conceived or reduced to practice, or may develop, make, conceive or reduce to
practice, during my employment by the Company, either solely or jointly with others (collectively, &ldquo;Developments&rdquo;).
All such Developments are and shall be the sole property of the Company, and I hereby assign to the Company, without further compensation,
all my right, title and interest in and to such Developments and any and all related patents, patent applications, copyrights,
copyright applications, trademarks and trade names in the United States and elsewhere.</TD></TR>                                                                                                <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.3in"></TD><TD STYLE="width: 0.3in">(b)</TD><TD STYLE="text-align: justify">I will keep and maintain adequate and current written records of all Developments
(in the form of notes, sketches, drawings, and as may be specified by the Company), which records shall be available to and remain
the sole property of the Company at all times.</TD></TR>                                                        <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify; padding-right: 0.25in">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.3in"></TD><TD STYLE="width: 0.3in">(c)</TD><TD STYLE="text-align: justify">I will assist the Company in obtaining and enforcing patent, copyright and other forms of legal
protection for the Developments in any country. Upon request, I will sign all applications, assignments, instruments, and papers
and perform all acts necessary or desired by the Company and to enable the Company, its successors, assigns and nominees, to secure
and enjoy the full exclusive benefits and advantages thereof.</TD></TR>                                                                       <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.3in"></TD><TD STYLE="width: 0.3in">(d)</TD><TD STYLE="text-align: justify">I understand that my obligations under this section will continue after the
termination of my employment with the Company and that during my employment I will perform such obligations without further compensation,
except for reimbursement of expenses incurred at the request of the Company. I further understand that if the Company does not
employ me as an employee at the time I am requested to perform any obligations under the section, I shall receive for such performance
a reasonable per diem fee, as well as reimbursement of any expenses incurred at the request of the Company.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15in; text-align: justify">2. <B>Proprietary Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15in; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.3in"></TD><TD STYLE="width: 0.3in">(a)</TD><TD STYLE="text-align: justify">I recognize that my relationship with the Company has been and is, and will continue to be, one
of high trust and confidence by reason of my access to and contact with the trade secrets and confidential and propriety information
of the Company and its employment applicants, employees, customers and contractors. I will not at any time, either during my employment
with the Company or thereafter, disclose to others, or use for my own benefit or the benefit of others, any of the Developments
or any confidential, proprietary or secret information owned, possessed or used by the Company or its employment applicants, employees,
customers or contractors (collectively, &ldquo;Proprietary Information&rdquo;). I understand that notwithstanding the foregoing,
nothing in this Invention and Non-Disclosure Agreement prohibits me from reporting to any governmental official or an attorney
information concerning a possible violation of law, and that I may disclose trade secret information to a government official or
to an attorney and use it in certain court proceedings without fear of prosecution or liability provided I do so consistent with
18 U.S.C. 1833, as amended.</TD></TR>                                     <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.3in"></TD><TD STYLE="width: 0.3in">(b)</TD><TD STYLE="text-align: justify">By way of illustration, but not limitation, Proprietary Information includes
trade secrets, processes, data, know-how, marketing plans, forecasts, unpublished financial statements, budgets, licenses, prices,
costs and employee, customer and supplier lists, and all employment applicant, employee or customer personal information.</TD></TR>                                                                                                                                   <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify; padding-right: 0.1in">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.3in"></TD><TD STYLE="width: 0.3in">(c)</TD><TD STYLE="text-align: justify">My undertakings and obligations under this Section 2 will not apply,
                                                               however, to any Proprietary Information which: (a) is or becomes generally known to the public through no action on my part,
                                                               (b) is generally disclosed to third
parties by the Company without restriction on such third parties, or (c) is required to be disclosed by me within the scope of
my duties to the Company.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 18; Value: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.3in">&nbsp;</TD><TD STYLE="width: 0.3in">(d)</TD><TD STYLE="text-align: justify">Upon
termination of my employment with the Company or at any other time upon request, I will promptly deliver to the Company all notes,
memoranda, notebooks, drawings, records, reports, files and other documents (and all copies or reproductions of such materials)
in my possession or under my control, whether prepared by me or others, which contain Proprietary Information. I acknowledge that
this material is the sole property of the Company.</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0.6in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.55in; text-align: justify; text-indent: -0.2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15in; text-align: justify">3. <B>Absence of Restrictions
Upon Disclosure and Competition</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15in; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.3in"></TD><TD STYLE="width: 0.3in">(a)</TD><TD STYLE="text-align: justify">I hereby represent that, except as I have disclosed in writing to the Company, I am not bound by
the terms of any agreement with any previous employer or other party to refrain from using or disclosing trade secret or confidential
or proprietary information in the course of my employment with the Company or to refrain from competing, directly or indirectly,
with the business of such previous employer or any other party.</TD></TR>                                                                         <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.3in"></TD><TD STYLE="width: 0.3in">(b)</TD><TD STYLE="text-align: justify">I further represent that my performance of all the terms of this Agreement and as an employee of
the Company does not and will not breach any agreement to keep in confidence proprietary information, knowledge or data acquired
by me in confidence or in trust prior to my employment with the Company, and I have not and will not disclose to the Company or
induce the Company to use any confidential and proprietary information or material belonging to any previous employer or others.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15in; text-align: justify">4. <B>Other Obligations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-align: justify">I acknowledge that the Company
from time to time may have agreements with other persons or with the United States Government, or agencies thereof, which impose
obligations or restrictions on the Company regarding inventions made during the course of work under such agreements or regarding
the confidential nature of such work. I agree to be bound by all such obligations and restrictions, which are made known to me,
and to take all action necessary to discharge the obligations of the Company under such agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-align: justify"><B>Miscellaneous</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.3in"></TD><TD STYLE="width: 0.3in">(a)</TD><TD STYLE="text-align: justify">The invalidity or unenforceability of any provision of this Agreement shall
not affect the validity or enforceability of any other provision of this Agreement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.3in"></TD><TD STYLE="width: 0.3in">(b)</TD><TD STYLE="text-align: justify">This Agreement supersedes all prior agreements, written or oral, between
me and the Company relating to the subject matter of this Agreement. This Agreement may not be modified, changed or discharged
in whole or in part, except by an agreement in writing signed by me and the Company. I agree that any change or changes in my duties,
salary or compensation after the signing of this Agreement shall not affect the validity or scope of this Agreement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.35in"></TD><TD STYLE="width: 0.2in">(c)</TD><TD STYLE="text-align: justify">This Agreement will be binding upon my heirs, executors and administrators
and will inure to the benefit of the Company and its successors and assigns.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.3in"></TD><TD STYLE="width: 0.3in">(d)</TD><TD STYLE="text-align: justify">No delay or omission by the Company in exercising any right under this Agreement
will operate as a waiver of that or any other right. A waiver or consent given by the Company on any one occasion is effective
only in that instance and will not be construed as a bar to or waiver of any right on any other occasion.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.3in"></TD><TD STYLE="width: 0.3in">(e)</TD><TD STYLE="text-align: justify">I expressly consent to be bound by the provisions of this Agreement for the
benefit of the Company or any subsidiary or affiliate thereof to whose employ I may be transferred without the necessity that this
Agreement be re-signed at the time of such transfer.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.3in"></TD><TD STYLE="width: 0.3in">(f)</TD><TD STYLE="text-align: justify">This Agreement is governed by and will be construed as a sealed instrument
under and in accordance with the laws of the State of Maine.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 19; Value: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0; text-align: justify">I have read all of the provisions
of the IDEXX Invention and Non-Disclosure Agreement and I understand, and agree to, each of such provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: bottom; font-size: 10pt">
    <TD STYLE="width: 17%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Signature of Employee:</FONT></TD>
    <TD STYLE="width: 83%; border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font-size: 10pt">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-size: 10pt">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Printed Name of Employee:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font-size: 10pt">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-size: 10pt">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Date Signed by Employee:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font-size: 10pt">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 40%"><FONT STYLE="font-size: 10pt">&copy; 2016
    IDEXX Laboratories, Inc. All rights reserved.</FONT></TD>
    <TD STYLE="width: 60%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 20; Value: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Exhibit B</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm19207851_ex10-3img02.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0.45pt 0pt 0; color: #CC0000"><B>Non-Compete Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35in 0pt 0.05in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35in 0pt 0in">I, Jonathan (<FONT STYLE="color: #1B1B1B">Jay)
Mazelsky,</FONT> hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35in 0pt 0.05in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">1. <B>Non-Compete</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">While I continue to be employed
by or providing services as a consultant to or director of the Company and for a period of two (2) years after the Date of Termination
(as defined in my Second Amended and Restated Executive Employment Agreement with IDEXX Laboratories, Inc., dated as of the date
hereof (the &ldquo;<U>Employment Agreement</U>&rdquo;)), I will not directly or indirectly:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">(a)&nbsp;&nbsp;&nbsp;Engage (whether for compensation or without compensation) as an individual proprietor, independent contractor, consultant, partner,
stockholder, officer, employee, director, joint venturer, investor, lender, or in any other capacity whatsoever (otherwise than
as the holder of not more than one percent (1%) of the total outstanding stock of a publicly held company), in any business enterprise
which competes with the Company in any business area in which the Company is engaged including, but not limited to, the animal
and agricultural diagnostic field and the food and environmental testing field; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">(b)&nbsp;&nbsp;Recruit
or otherwise solicit or induce any employee of the Company to terminate their employment with, or otherwise cease their relationships
with, the Company; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">(c)&nbsp;&nbsp;&nbsp;Directly or indirectly induce or solicit (or assist any Person (as defined below) to induce or solicit) any customer, vendor, supplier,
or client of the Company to terminate its relationship or otherwise cease doing business in whole or in part with the Company,
or directly or indirectly interfere with (or assist any Person to interfere with) any material relationship between the Company
and any of its customers, vendors, suppliers, or clients so as to cause harm to the Company or any of its affiliated companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">As used herein, &ldquo;Person&rdquo;
shall mean any individual, corporation, partnership, limited liability company, association, trust or other entity or organization,
including a government or political subdivision or an agency or instrumentality thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 22.3pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">2. <B>Interpretation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">I consider the restrictions
against competition set forth in Section 1 to be reasonable for the purposes of protecting the business of the Company. However,
if any such restriction is found by any court of competent jurisdiction to be unenforceable because it extends for too long a period
of time or over too great a range of activities or in too broad a geographic area, I agree that it shall be interpreted to extend
only over the maximum period of time, range of activities or geographic area as to which it may be enforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in 0pt 0.05in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">3. <B>Miscellaneous</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">(a) &nbsp;The
invalidity or unenforceability of any provision of this agreement shall not affect the validity or enforceability of any other
provision of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">(b)&nbsp;&nbsp;This
Agreement will be binding upon my heirs, executors and administrators and will inure to the benefit of the Company and its successors
and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">(c) &nbsp;No
delay or omission by the Company in exercising any right under this Agreement will operate as a waiver of that or any other right.
A waiver or consent given by the Company on any one occasion is effective only in that instance and will not be construed as a
bar to or waiver of any right on any other occasion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">(d)&nbsp;&nbsp;I expressly consent to be bound by the provisions of this Agreement for the benefit of the Company or any subsidiary or affiliate
thereof to whose employ I may be transferred without the necessity that this Agreement be re-signed at the time of such transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">(e)&nbsp;&nbsp;This Agreement is governed by and will be construed as a sealed instrument under and in accordance with the laws of the State of
Maine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0.25in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 21; Value: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0in; text-align: justify">I have read all of the provisions
of this IDEXX Non-Compete Agreement and I understand, and agree to, each of such provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0.05in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 18%; font: 10pt Times New Roman, Times, Serif">Signature of Employee:</TD>
    <TD STYLE="width: 82%; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Printed Name of Employee:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Date signed by Employee:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0.05in; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0.05in; text-align: justify"></P>

<!-- Field: Page; Sequence: 22; Value: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0.05in; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B"><B><U>Exhibit C</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B"><FONT STYLE="font-variant: small-caps"><B>You
should consult with an attorney before signing this release of claims.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B"><B>RELEASE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B">Capitalized terms used in
this release and defined in the Employment Agreement (defined below) shall have the meanings given to such terms under the Employment
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #1B1B1B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>In consideration of the payments and benefits to be made under the Second Amended and Restated Executive Employment Agreement,
dated as of October 23, 2019 (the &ldquo;<U>Employment Agreement</U>&rdquo;), by and between Jonathan (Jay) Mazelsky (the &ldquo;<U>Employee</U>&rdquo;
or &ldquo;<U>you</U>&rdquo;) and IDEXX Laboratories, Inc. (the &ldquo;Company&rdquo;), its subsidiaries and affiliates (hereinafter
collectively referred to as &ldquo;<U>IDEXX</U>&rdquo;), the sufficiency of which you acknowledge, by signing this general release
of claims (the &ldquo;<U>Release</U>&rdquo;), you and your heirs and assigns hereby fully, forever, irrevocably and unconditionally
release and discharge IDEXX Laboratories, Inc., its subsidiaries and affiliates, and all of their respective former and current
officers, directors, owners, stockholders, affiliates, agents, employees, and attorneys (collectively the &ldquo;<U>Released Parties</U>&rdquo;)
from, and waive, any and all claims, charges, or actions of any kind which you have ever had or now have through the Release Effective
Date (as defined in Paragraph 4.h below), whether known or unknown, against any or all of the Released Parties, arising out of
or relating to your employment or termination from employment, including but not limited to claims under the Employment Agreement,
claims under any severance plan maintained by IDEXX, claims for discrimination based on race, sex, disability, national origin,
age, religion, color, ancestry, marital or family status, pregnancy, sexual orientation, and any other legally protected attribute
or status, and including without limitation claims under Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991,
the Rehabilitation Act of 1973, the Employee Retirement Income Security Act, the Equal Pay Act, the Americans with Disabilities
Act, the Family and Medical Leave Act, the National Labor Relations Act, the Maine Human Rights Act, and all other applicable state
laws, including but not limited to, laws pertaining to wrongful discharge claims, defamation claims, retaliation claims, unpaid
wage claims, or other statutory or common law or contract claims. You acknowledge that this release releases the Released Parties
in both their corporate and their individual capacities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Without limiting the
above, this Release also constitutes a release of any claims you may have, as of the Release Effective Date, against the Released
Parties, pursuant to the Age Discrimination in Employment Act, as amended (which is the federal statute which makes it illegal
for an employer to discharge or otherwise discriminate against an employee because of the employee&rsquo;s age), including any
possible claims relating to termination of your employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">It is the specific
intent and purpose of this Release to release and discharge any and all claims and causes of action of any kind or nature whatsoever
as aforesaid to the full extent such release is allowed by law, from the beginning of time until the present day, whether such
claims and causes of action are known or unknown and whether specifically mentioned or not. You acknowledge that you are aware
that statutes exist that render null and void releases and discharges of claims and causes of actions that are unknown to the
releasing or discharging party at the time of execution of the release and discharge. You hereby expressly waive, surrender and
agree to forego any protection to which you would otherwise be entitled by virtue of the existence of any such statute in any
jurisdiction, including, but not limited to, the State of Maine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 23; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You agree not only
to release and discharge the Released Parties from any and all claims against the Released Parties that you could make on your
own behalf, but also those which may have been or may be made by any other person or organization on your behalf.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You specifically waive
any right to become, and promise not to become, a party to any case or proceeding or a member of any class in a case or proceeding
in which any claim or claims are asserted against the Released Parties involving any event which has occurred as of the Date of
Termination. If you are asserted to be a member of a class in a case or proceeding against the Released Parties involving any events
occurring prior to or as of the Release Effective Date, you shall immediately withdraw with prejudice in writing from said class,
if permitted by law to do so. You agree that this Release is, will constitute and may be pleaded as a bar to any such case or proceeding.
You represent that you have no lawsuits, claims or actions pending in your name, or on behalf of any other person or entity, against
the Released Parties and that you do not intend to bring any lawsuits, claims or actions on your own behalf or on behalf of any
other person or entity against any Released Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">2.</TD><TD STYLE="text-align: justify"><U>Exceptions to the Release</U>. Notwithstanding the
Release set forth above in Paragraph 1, this Release is not a waiver by you of (1) any right or claim that may arise after the
Release Effective Date, (2) any right or claim to unemployment compensation, (3) any vested retirement and profit sharing benefits
for which you are eligible in accordance with the terms of the respective employee benefit plans, (4) your right to indemnification
from the Company under the certificate of incorporation or bylaws of the Company and in accordance with applicable law, (4) the
Accrued Obligations, (5) any rights you may have as a holder of Company common stock or equity-based incentive awards, or (6)
any rights under to severance payments or benefits, as applicable, under Section 4(a) or 5(c) of the Employment Agreement, as
applicable, or that may not be released by law. This is also not a waiver of any claim you may have for workers&rsquo; compensation
benefits although you hereby represent to IDEXX that you do not know of any such claims and that you do not believe that you have
any workplace injury relating to your employment with IDEXX. Further, nothing in this Release or the Employment Agreement (and
any exhibits thereto) will be construed to affect the independent right and responsibility of the Equal Employment Opportunity
Commission (&ldquo;<U>EEOC</U>&rdquo;) or a state or local fair employment practices agency acting as an EEOC referral agency
to enforce employment discrimination laws. Signing this Release will not interfere with your right to file a charge or participate
in an investigation or proceeding conducted by the EEOC or the state or local agency as long as you do not seek or accept any
damages, remedies, or other relief for yourself personally, which you promise not to do, and any right to which you specifically
waive. You understand that unless a court invalidates this Release, you have no right to recover damages against the Released
Parties for your claims. <FONT STYLE="color: #191919">Notwithstanding anything to the contrary contained herein, no provision
of this Release or the </FONT>Employment <FONT STYLE="color: #191919">Agreement (or any exhibits thereto) shall be interpreted
so as to impede you (or any other individual) from reporting possible violations of federal law or regulation to any governmental
agency or entity, including but not limited to the Department of Justice, the Securities and Exchange Commission, the United States
Congress, and any agency Inspector General, or making any other disclosures under the whistleblower provisions of United States
federal law or regulation. You do not need the prior authorization of IDEXX to make any such reports or disclosures and you shall
not be required to notify IDEXX that such reports or disclosures have been made.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>No Admissions</U>. Nothing contained herein shall be construed as an admission by IDEXX of any liability or unlawful
conduct whatsoever. You agree and understand that the severance payments and benefits provided pursuant to Section 4(a) or 5(c)
as applicable, of the Employment Agreement are provided solely in consideration of your execution of this Release and your obligations
under the Ancillary Agreements, and that the payments and benefits are sufficient consideration for the Release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Knowing Consent to Release</U>. By signing below you understand and agree that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">a.</TD><TD STYLE="text-align: justify">You have the option to take a full [<B>twenty-one (21)] days</B> from [&#9679;], the date the Release
was provided to you by IDEXX, within which to consider this Release before executing it. If you sign this Release sooner than [twenty-one
(21)] days from when it was provided to you, you do so with the understanding that you could have taken the entire [twenty-one
(21)]-day period to review this Release.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">b.</TD><TD STYLE="text-align: justify">You have carefully read and fully understand all of the provisions of this Release.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">c.</TD><TD STYLE="text-align: justify">You are, through this Release, releasing the Released Parties from any and all claims you may have
against the Released Parties.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">d.</TD><TD STYLE="text-align: justify">You knowingly and voluntarily agree to all of the terms set forth in this Release.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">e.</TD><TD STYLE="text-align: justify">You knowingly and voluntarily intend to be legally bound by the same.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">f.</TD><TD STYLE="text-align: justify">You have been advised in writing to consider the terms of this Release and consult with an attorney
of your choice prior to executing this Release.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">g.</TD><TD STYLE="text-align: justify">You acknowledge that the consideration set forth in the Section 4(a) or 5(c), as applicable, of
the Employment Agreement is above and beyond anything you might otherwise be entitled to receive.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">h.</TD><TD STYLE="text-align: justify">You have a full <B>seven (7) days after</B> executing this Release to revoke this Release by delivering
written notice of revocation to the Company&rsquo;s Chief Human Resources Officer, and are hereby advised in writing that this
Release shall not become effective or enforceable until the revocation period has expired. If the Release is not revoked, it shall
become effective and irrevocable on the day next following the day on which the foregoing revocation period has expired (the &ldquo;<U>Release
Effective Date</U>&rdquo;). In case of revocation, the obligations of each party to this Release shall become null and void.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Choice
of Law</U>. This Release shall be governed by and construed in accordance with the laws of the State of Maine. You agree and consent
to submit to personal jurisdiction in the State of Maine in any state or federal court of competent subject matter jurisdiction
situated in Cumberland County, Maine. You further agree that the sole and exclusive venue for any suit arising out of, or seeking
to enforce, the terms of this Release and the Employment Agreement (including all exhibits thereto) shall be in a state or federal
court of competent subject matter jurisdiction situated in Cumberland County, Maine. In addition, you waive any right to challenge
in another court any judgment entered by such Cumberland County court or to assert that any action instituted by IDEXX in any
such court is in the improper venue or should be transferred to a more convenient forum. <B>In addition, you and IDEXX also waive
any right you or it may otherwise have to a trial by jury in any action to enforce the terms of this Release.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">(j)</TD><TD STYLE="text-align: justify">No delay or omission by IDEXX in exercising any right under this Release shall operate as a waiver
of that or any other right. A waiver or consent given by IDEXX on any one occasion shall be effective only in that instance and
shall not be construed as a bar or waiver of any right on any other occasion.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">(k)</TD><TD STYLE="text-align: justify">The captions of the sections of this Release are for convenience of reference only and in no way
define, limit or affect the scope or substance of any section of this Release.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">(l)</TD><TD STYLE="text-align: justify">In case any provision of this Release shall be invalid, illegal or otherwise unenforceable, the
validity, legality and enforceability of the remaining provisions shall in no way be affected or impaired thereby.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">(m)</TD><TD STYLE="text-align: justify">Nothing in this Release precludes you from providing truthful testimony when lawfully subpoenaed
or otherwise required to do so by law.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">(n)</TD><TD STYLE="text-align: justify">By signing this Release, you hereby represent that to the best of your knowledge you did not commit
any act, or fail to commit any act, or do anything else while employed by IDEXX that was a breach of your duty of loyalty (including
but not limited to taking any property that belongs to IDEXX or its customers) or that might result in liability to IDEXX.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">(o)</TD><TD STYLE="text-align: justify">This Release may not be altered, amended or modified except in writing signed by both IDEXX and
you.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">(p)</TD><TD STYLE="text-align: justify">If any provision of this Release shall be found by a court of competent jurisdiction to be invalid
or unenforceable, in whole or in part, then such provision shall be construed and/or modified or restricted to the extent and in
the manner necessary to render the same valid and enforceable, or shall be deemed excised from this Release, as the case may require,
and this Release shall be construed and enforced to the maximum extent permitted by law, as if such provision had been originally
incorporated herein as so modified or restricted, or as if such provision had not been originally incorporated herein, as the case
may be. The parties further agree to seek a lawful substitute for any provision found to be unlawful; provided, that, if the parties
are unable to agree upon a lawful substitute, the
parties desire and request that a court or other authority called upon to decide the enforceability of this Release modify this
Release so that, once modified, this Release will be enforceable to the maximum extent permitted by the law in existence at the
time of the requested enforcement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Complete Agreement</U>. This Release and the Employment Agreement (and all exhibits thereto) constitute the complete
understanding between you and IDEXX with respect to your separation from employment, and this Release supersedes all prior representations,
agreements, and understandings, both written and oral, between you and IDEXX with respect to the subject matters hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Counterparts</U>. This Release may be executed in several counterparts, each of which shall be deemed to be an original,
but all of which together shall constitute one and the same instrument. Signatures delivered in .pdf format shall be deemed effective
for all purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1B1B1B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1B1B1B"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1B1B1B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #0B0B0B">Please sign
and return <B><I>a complete copy of this Release </I></B>to the Company&rsquo;s Chief Human Resources Officer, indicating your
agreement to all of the terms of the Release. This Release shall expire if not signed by you and returned to the Company&rsquo;s
Chief Human Resources Officer by no later than the close of business on </FONT>[&#9679;]<FONT STYLE="color: #0B0B0B">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1B1B1B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1B1B1B">IDEXX</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1B1B1B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1B1B1B">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: #1B1B1B; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: #1B1B1B">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: #1B1B1B; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 49%; font: 10pt Times New Roman, Times, Serif; color: #1B1B1B">By:</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; color: #1B1B1B">&nbsp;</TD>
    <TD STYLE="width: 49%; font: 10pt Times New Roman, Times, Serif; color: #1B1B1B">Date:</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: #1B1B1B">Title:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1B1B1B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; color: #0B0B0B"><B>You have been advised that at least [twenty-one
(21)] calendar days will be provided for the review of this Release, and to consult with an attorney prior to the execution of
this Release.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0B0B0B"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; color: #0B0B0B"><B>You represent and agree that you have carefully
read and fully understand all of the provisions of this Release and that you have voluntarily entered into this Release.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0B0B0B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accepted and Agreed To:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: #1B1B1B; text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: #1B1B1B">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: #1B1B1B; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 49%; font: 10pt Times New Roman, Times, Serif; color: #1B1B1B; text-align: left">Jonathan (Jay) Mazelsky</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; color: #1B1B1B">&nbsp;</TD>
    <TD STYLE="width: 49%; font: 10pt Times New Roman, Times, Serif; color: #1B1B1B">Date:</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 28; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>



<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>tm19207851_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>IDEXX Laboratories Announces Leadership
Changes</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Jay Mazelsky Appointed President and
Chief Executive Officer and Elected to IDEXX Board </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Jonathan Ayers Will Continue as a Member
of the IDEXX Board and Serve as a Senior Advisor to the Company </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Lawrence Kingsley Assumes Role of Independent
Chairman of the Board </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>WESTBROOK, Maine, October 24, 2019</B>&mdash;IDEXX Laboratories,
Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, today
announced that Jonathan Ayers is stepping down as Chairman and a member of the IDEXX management team, effective November 1, 2019.
This decision follows Mr. Ayers&rsquo;s previously announced medical leave of absence from IDEXX due to a bicycling accident, where
he suffered a spinal cord injury.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The IDEXX Board of Directors has appointed Jonathan (Jay) Mazelsky,
who has been serving as Interim President and Chief Executive Officer since June 28, 2019, as President and Chief Executive Officer,
effective immediately. Mr. Mazelsky has also been elected to the IDEXX Board. Lawrence Kingsley, Lead Director, has been appointed
as Independent Chairman of the IDEXX Board, effective November 1, 2019. Mr. Ayers will continue as a member of the IDEXX Board
and serve as a Senior Advisor to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Mr. Ayers said, &ldquo;While the nature of my spinal cord injury
and my continuing need to focus on an extended rehabilitation process preclude me from returning to IDEXX as CEO, my passion for
the Company and its Purpose has not diminished. I am extremely proud of the significant long-term value we have created during
my 17-year tenure with IDEXX, and it has been a true privilege to work with our outstanding management team, Board and employees.
I am delighted with Jay&rsquo;s appointment as President and CEO and have complete confidence in his ability to lead IDEXX forward.
I look forward to continuing to support the Company as a member of the Board and as a Senior Advisor, and I know much success lies
ahead for IDEXX.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;On behalf of the Board, management team and
employees of IDEXX, I thank Jon for his leadership, vision and unwavering commitment over his distinguished career at the
Company,&rdquo; said Mr. Kingsley. &ldquo;Under Jon&rsquo;s guidance and stewardship, IDEXX has built a strong foundation for
growth and the Company is well-positioned to drive continued innovation, accelerate product development and enhance
profitability. We look forward to Jon&rsquo;s continued meaningful contributions to IDEXX as a Board member and Senior
Advisor, and we wish him all the best as he continues his rehabilitation process.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr. Kingsley concluded, &ldquo;Jay is an exceptionally
talented and well-respected leader with deep industry experience and institutional knowledge, and the Board is confident that
his expertise and strategic insight make him the ideal candidate to succeed Jon in the CEO role. Jay has done an outstanding
job in the past four months since he assumed the responsibilities of President and CEO on an interim basis, and we look
forward to IDEXX&rsquo;s continued growth and success under his leadership.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr. Mazelsky stated, &ldquo;I am thrilled to lead IDEXX and
I look forward to further building on our progress and driving enduring long-term value for shareholders and customers by advancing
our Purpose to enhance the health and well-being of pets, people and livestock. I thank Jon for his mentorship and leadership
of the Company and look forward to his continued contributions as a Board member and Senior Advisor.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Jay Mazelsky</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Prior to his appointment as Interim President and Chief Executive
Officer of IDEXX, Mr. Mazelsky, 59, was an Executive Vice President responsible for the Company&rsquo;s North American Companion
Animal Group Commercial Organization and key elements of the innovation portfolio, including IDEXX&rsquo;s global in-house diagnostics
and Veterinary Software and Service&rsquo;s businesses. He joined IDEXX in August 2012 as Executive Vice President. From 2010 to
2012, Mr. Mazelsky was a Senior Vice President and General Manager of Computed Tomography, Nuclear Medicine and Radiation Therapy
Planning at Philips Healthcare, a subsidiary of Royal Philips Electronics. He holds an undergraduate degree in Mathematics from
the University of Rochester and an M.B.A from The University of Chicago Booth School of Business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Lawrence Kingsley</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr. Kingsley served as Chairman of Pall Corporation from 2013
to 2015 and as Chief Executive Officer of Pall Corporation from 2011 to 2015, and he has served as an Advisory Director to Berkshire
Partners LLC, a Boston-based investment firm, since spring of 2016. Prior to that, Mr. Kingsley was the Chief Executive Officer
and a member of the Board of Directors of IDEX Corporation, a company specializing in fluid and metering technologies, health and
science technologies and fire, safety and other diversified products, from 2005 to 2011, and the Chief Operating Officer of IDEX
from August 2004 to March 2005. From 1995 to 2004, he held various positions of increasing responsibility at Danaher Corporation,
including Corporate Vice President and Group Executive of Danaher Corporation. Mr. Kingsley has been a director on the Board of
Polaris Industries Inc. since 2016 and Rockwell Automation, Inc. since 2013. Mr. Kingsley holds an undergraduate degree in Industrial
Engineering and Management from Clarkson University and an M.B.A. from the College of William and Mary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About IDEXX Laboratories</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">IDEXX Laboratories, Inc. is a member of the S&amp;P 500<SUP>&reg;
</SUP>Index and is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range
of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide
advanced medical care, improve staff efficiency and build more economically successful practices. IDEXX is also a worldwide leader
in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk.
Headquartered in Maine, IDEXX employs more than 8,000 people and offers products to customers in over 175 countries. For more
information about IDEXX, visit: www.idexx.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Note Regarding Forward-Looking Statements </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This news release contains or may contain forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the
use of words such as &ldquo;expects,&rdquo; &ldquo;may,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;intends,&rdquo; &ldquo;would,&rdquo;
 &ldquo;will,&rdquo; &ldquo;plans,&rdquo; &ldquo;believes,&rdquo; &ldquo;estimates,&rdquo; &ldquo;should,&rdquo; &ldquo;project,&rdquo;
and similar words and expressions. These forward-looking statements are intended to provide our current expectation or forecasts
of future events; are based on current estimates, projections, beliefs, and assumptions; and are not guarantees of future performance.
Actual events or results may differ materially from those described in the forward-looking statements, as well as a number of assumptions
concerning future events. These statements are subject to risks, uncertainties, assumptions and other important factors. Readers
are cautioned not to put undue reliance on such forward-looking statements because actual results may vary materially from those
expressed or implied. The reports filed by IDEXX pursuant to United States securities laws contain discussions of these risks and
uncertainties. IDEXX assumes no obligation to, and expressly disclaims any obligation to, update or revise any forward-looking
statements, whether as a result of new information, future events or otherwise. Readers are advised to review IDEXX&rsquo;s filings
with the United States Securities and Exchange Commission (which are available from the SEC&rsquo;s EDGAR database at www.sec.gov
and via IDEXX&rsquo;s website at www.idexx.com).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm19207851_ex99-1img01.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Contact</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Investor Relations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">IDEXX Laboratories</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">John Ravis</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1-207-556-8155</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">john-ravis@idexx.com</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>idxx-20191023.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +K85w7xRiXgen8uNbXAsWaCJmbPtzp5x+ekhuWh9bUl6zyYkvF0jpiWo2CAm4TYN -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:idxx="http://idexx.com/20191023" elementFormDefault="qualified" targetNamespace="http://idexx.com/20191023">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://idexx.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="idxx-20191023_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="idxx-20191023_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>idxx-20191023_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>idxx-20191023_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://idexx.com/role/Cover" xlink:href="idxx-20191023.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://idexx.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>tm1920785-1_8kimg01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm1920785-1_8kimg01.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  L / # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#T.O0?@'_R
M5;0O]^3_ -%/7GU>@_ /_DJVA?[\G_HIZLD[K]K'_D,:'_UP;_T(UX)7O?[6
M/_(8T/\ ZX-_Z$:\$498"D#"BOI/PC^S?X<U[PKI&I3WVHI/=VL<[K&\>T,R
M@D#*=.:UO^&6/"__ $$-4_[[B_\ B* /E:KFGZQ?:2Q:RO)K1CSF&0J?TKZ=
M_P"&6/"__00U3_ON+_XBN>\6_LLQV^FRSZ!J4T]Q&I86UTHS)CL&&!G\/Q%
M'!>$?V@/%7AF9!<7C:O:# :&\8N<>SGY@?QQ[5]1>!/'>F_$#1%U#3V*D';-
M Q^>)O0^WH>_YBOA26-H9&C<%74X(->J?LW>(Y='^(<%CO;[/J*-"Z]LA2RG
MZY7'_ C0!>_:F_Y*!:_]@^/_ -#DKQNO9/VIO^2@6O\ V#X__0Y*\=A4-*BG
MH2 : 8VBOKG2_P!GOP7=:79S26,YDDA1V/VANI4$U:_X9T\$?\^$_P#X$O\
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M+NM:U""RLH7N+J9PD<:#))-;?CKX?ZM\/M22SU2)09$#QS1DLCCO@X['@_\
MZL_3?P7^$,/@#35OKZ-9-=N%^=NOD*?X![^I_#W/7^./!.G>/="ETW48^#\T
M4RCYX7[,/ZCN*+A8^%K*\GTZ[ANK:1H9X7#I(AP58'((-?8GP;^*T'Q$T?R;
MEEBUJU4">/IY@Z>8H_F.Q]B*^5?''@G4/ >O3:;J$>"IS'*OW9%[,#Z?_7]*
MI>&_$=]X4UBWU/3IC#<P-N4CH?8CN#Z>] 'WU+*D$;R2.L<: LSL<!0.I)]*
M^2OCE\77\<:D=,TZ1DT2U?C''GN.-Y]O0?U/%WXI?'Z7QGX=M-+TV*2Q2:,-
M?G/WF_N*?[G&?4Y'ISXUUH  "Q  R37T?\!?@I]E^S^)=>A_>\265I(/N]Q(
MP_D/Q]*R_@+\%?[2:#Q'KL'^AJ=UI:R#_6G^^P_N^GK].OTK0,_.^O0?@'_R
M5;0O]^3_ -%/7GU>@_ /_DJVA?[\G_HIZ8CZB\:?"_0_'UQ;S:O'-(]NI1/+
MDVC!.?2N;_X9O\%CG[-=?]__ /ZU<A^TQXJU?P[JVCKIFI75BLD#%UMYFC#'
M=U.",UXNOQ-\5E@/^$AU/K_S]R?_ !52,^W-'TN#0]*L].M0PMK6)88PQR=J
MC R>_ JY7/\ P^N9KSP+X?N+F5Y[B6QA>220DLS% 22>Y-=!2&%%%9/B3Q1I
MGA/2YK_4[J.VAC4L Q&YS_=4=R?04 <7J'[/O@_4KZXNYK:X\V>1I'VS8&2<
MG''O5KP]\#O"WA?6+;4[&"X2ZMVW(6ER,XQTQ7S!JWQ7\3WFIW=Q#KFHP12R
MLZQ)=2!4!.< 9Z"NL^#/C7Q+KOQ(T>TN=8U"[MV=C)')<NRE0C'D$X[4Q'O_
M (Q^$?A[QUJBZAJL4\ERL2P@QR[1M!)'&/\ :-8:_LX^#%8$6]T".1^__P#K
M5Y=^TUJ][I_CZV2VNYH$-A&2J.0,[Y.<5Y-#XFU4S(#J%P1N'_+0TP/HS]J+
MQIK7PS^'.DW/AN_?3KC[=';&155R8_*D./F![J/RKY7_ .&GOB9_T-,W_@/#
M_P#$5]V:EX)T3Q[X5TJR\0:?'J=M&D<RQS,W#[,;L@@YPQ_.L#_AG'X;_P#0
MJ6G_ '\D_P#BJ^=QN"Q=>MST:G*NUVOR/U7AWB+(LMP*P^/P?M*EV^;D@]'M
MK)W/C+_AI[XF?]#3-_X#P_\ Q%'_  T]\3/^AIF_\!X?_B*^S?\ AG'X;_\
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M@OX@!<VN>4;U'JI['\*[*I*/SOKT'X!_\E6T+_?D_P#13US_ /8-MZR?F/\
M"NY^">D06_Q-T61"^Y7D/)'_ #R?VJR#H?VL?^0QH?\ UP;_ -"->"5]&?M.
M:?%>:QHOF%N('^Z?]JO%/[!MO63\Q_A0-E"'Q-JUO"D46I74<: *JK*P  ["
MG_\ "6:U_P!!6[_[_-_C5S^P;;UD_,?X4?V#;>LGYC_"@13_ .$LUK_H*W?_
M '^;_&J-UJ%S?/ON)Y)FZ;G;)K:_L&V]9/S'^%=5X'^'&E^)+A8[J2Y0%L9B
M=0?U4T >:*I8X R:^G/V<OA;=>'XY/$>J0F&XN(_+M87&&5#R7([9X ]L^HK
MM_"'P5\*>$WCN;>P-W=* 5GO&$A!]0,!0??&:[VI*/E/]J;_ )*!:_\ 8/C_
M /0Y*\;!*D$'!KWC]I'38KSQU;/(6S]AC'RG_;D_QKRC^P;;UD_,?X50F78O
MBUXNAB2--?OE1 %51.V !T'6G?\ "WO&/_0P7W_?]O\ &J']@VWK)^8_PH_L
M&V]9/S'^% B__P +>\8_]#!??]_V_P :/^%O>,?^A@OO^_[?XU0_L&V]9/S'
M^%']@VWK)^8_PH ^G/@;XNN=0^'-WJVNZBTHAN9-]S=2$[$"(>I[<G\Z\/\
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;$=_X/\465SILQ0R2I%)&_*2*S $$55A7/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>tm19207851_ex10-1img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm19207851_ex10-1img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  : (,# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#K8=<U4SQ
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KN+F;$$7^L;^ >M '?1RI+&LD;!D89##H117'VA,=LB(2JC. O '-% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>tm19207851_ex10-1img02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm19207851_ex10-1img02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  ; J8# 2(  A$! Q$!_\0
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MK:9H,VIW,EUJ[0S,V73CY3CZ4 9?_"1^(B,^9)_X#C_"D;Q-X@C&YY65?5H
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M"Q15?SKC_GU/_?8H\ZX_Y]3_ -]B@"Q15?SKC_GU/_?8H\ZX_P"?4_\ ?8H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
>4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>tm19207851_ex10-3img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm19207851_ex10-3img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  ; 'T# 2(  A$! Q$!_\0
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MX>\06B'P);65W)!)XNU26&Z\G382T$\]D;5K.;^V+J:*06"0W/GQO<+;Q/\
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M\D]R>O>C_A4WPK_Z)I\/_P#PC?#G_P K:!G\P/Q!^*'QH_:L\<:7<ZK!J'Q
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196ED8%E)!D<C!=L@DK:(_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>tm19207851_ex10-3img02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm19207851_ex10-3img02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  D P\# 2(  A$! Q$!_\0
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M1D?<% 'U;J'_  43^&VEW\]M->:D);>1HG M,@,IP>_J*A_X>0_#'_G]U/\
M\ __ +*OS[\>0E/&^LOLD(%].WW3R/,:OHSP9_P2_P!4\5^%-*U)?%-C&+^R
MAN2C0,2I= V,_C0![Q_P\A^&/_/[J?\ X!__ &5=/X%_;)\ ?$.YCAT_7[1+
MB5@%AN@8'.3C SP3^-?-]U_P2DUF)&V>*M.=]N54P, 3[FOGGXR_!S5O@?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **CW4Y#F@"MJ>IC2[.:=P2D"ER%&20!GBL+Q-\5]*\(Z =1O[F.&()'(
M8S_K=KE0IVYSU89J;XGVLMWX#UU(0[2O82K&J'YBVQL8_2OE[XCZ+!>>"-5T
MS5=$U:_\;2FSGLFBAD9_LJB#&&^Z H60,/4&@#ZP3Q- 9S$TT'F ;]N\;@O
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M Q%T/5@/^0NO_@*/_BJ4Z%J?_05C_P# 0?\ Q5;5% &*-"U/_H*I_P" @_\
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>tm19207851_ex99-1img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm19207851_ex99-1img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  8 '<# 2(  A$! Q$!_\0
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MMX2TV77M8U3]I.'3;!/M-W<P_$+Q5K'V>* $SS36.G^)-6N?L^/^G3/U%?T
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M9?%/Q?>2:/KUEH6E66N^)=)FM_$=W_:%L=1^WGQ.;0$6A_XGMAFQ^V?8\/\
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MU)8X4BAA0>'O!.$B@'?_ (IO/MVSV%2']NG]JT+C_A;VJ#W/A[P3GU_Z%O\
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JP;'2K2:>?P[KB6YNKEOL5A;SMHNICYC:6_V"](/V,44443^)_+\C0__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>tm19207851_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="idxx-20191023.xsd" xlink:type="simple"/>
    <context id="From2019-10-22to2019-10-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874716</identifier>
        </entity>
        <period>
            <startDate>2019-10-22</startDate>
            <endDate>2019-10-23</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2019-10-22to2019-10-23">0000874716</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2019-10-22to2019-10-23">false</dei:AmendmentFlag>
    <dei:EntityRegistrantName contextRef="From2019-10-22to2019-10-23">IDEXX LABORATORIES INC /DE</dei:EntityRegistrantName>
    <dei:DocumentType contextRef="From2019-10-22to2019-10-23">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2019-10-22to2019-10-23">2019-10-23</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="From2019-10-22to2019-10-23">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2019-10-22to2019-10-23">000-19271</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2019-10-22to2019-10-23">01-0393723</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2019-10-22to2019-10-23">One IDEXX Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2019-10-22to2019-10-23">Westbrook</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2019-10-22to2019-10-23">ME</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2019-10-22to2019-10-23">04092</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2019-10-22to2019-10-23">207</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2019-10-22to2019-10-23">556.0300</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2019-10-22to2019-10-23">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2019-10-22to2019-10-23">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2019-10-22to2019-10-23">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2019-10-22to2019-10-23">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2019-10-22to2019-10-23">Common     Stock, $0.10 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2019-10-22to2019-10-23">IDXX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2019-10-22to2019-10-23">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2019-10-22to2019-10-23">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.19.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>97</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm19207851_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://idexx.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm19207851_8k.htm">tm19207851_8k.htm</File>
    <File>idxx-20191023.xsd</File>
    <File>idxx-20191023_lab.xml</File>
    <File>idxx-20191023_pre.xml</File>
    <File>tm19207851_ex10-1.htm</File>
    <File>tm19207851_ex10-2.htm</File>
    <File>tm19207851_ex10-3.htm</File>
    <File>tm19207851_ex99-1.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>tm1920785-1_8kimg01.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001104659-19-055983-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-19-055983-xbrl.zip
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M(<"1#$+-*/\XS5G$Q3.OO4XQXUO9).YG/(9'+CU1;M$:5(0F8)TA 6$VQ"<
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MF7W/?V>?>_?G[KV_9T.CT#0@86MI8PG 8#  QWT :!RP . \/+\7UQ#<Q2O
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MVD;JP-5&QE#U1S?TE4?AA>P&=$=C'I-O?-B^DQ!SYEGP@8>7=&+5$@V8WT[
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MSUFR\A,Z80@G9PP:^O+O4$L#!!0    ( "X\6$]ON*AUVR$  ,S6   1
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M;TM2B;S=L ^RQBEYE@UCV:#JY(..Y7G60#[[K1EB*FY6UWV"G%*BAMZ#9:G
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M.MR18 ZAPIH 8NL24<H"BA$]!&)0-ZB4>*6ZUZJ[%U1U=Q^4\1!)\\,^4V]
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M3A:>F<F1=.X6X$TU_/YFJ?QTQ_52P5 %M(1(:$3=>8C?LE'0^28&-J4G+E(
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M0:V(V'V88,(>8.E+%T 4O!+?YE6K5:6X6:D(3N&1C5B9(P4ZEB&X#!,^TZI
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M/'/"YRM/HZ15^L7E[4W\,>DB)XV]%?O)=\XZ3ZJ\_IHJ?]Q4>>TU5?X@S/>
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M";"?EU$BNQ=_@QO+ZJ Q?FL54$ME\1Z=MH,#K;"YT76IM\=@,IPJBHMBI.F
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M?( .M6(#<A 9#?YP]^E1X-=1.!(.[1'[IL8JY-T#/R-G% /.P5&IY*CLHS6
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MJJ[!D)'7PF!C%0D^JHJ.['SA;7!3@G7IYP*F7AL=8P03#"3[ZA7;HYL;'BY
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M9!W ]CO9^851#S3& ^^$]7[+#YN'P6'#D4T7%'QIO'Z*(N05+X>),>Y$IS[
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MRDBFBH:UWA1?O"D>!YOB5P(1]D#3Y;7*.$3S1UH9-<=QCE/!-E2VNL1N":<
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M3VGS9HOR @^*AMI7- (SEH'W_H5?HV0>O1;?E8MOWXGO.7%I2Y,9,>XKT[T
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M!='U("TK@=='"Z+K-S<^#UZ_=!CE71(GW2%.'LZ=(OTK +H;^9F/<\= ZVJ
M[M$<G/O2+)));IV[X^H/IAP-JP6>1S-QYYL;!GB^FJW[S9S[@\!V_4(8.A)'
M4Y+5RUC?3MCYK+==/?9\(:CY=&3YDQM!P$TEA\4'C>I)KD&V]Q?$H!\\7<T
M;H02[@"J?^FH%H+#WPC6/XO\,7CP?/"UF?N;+?Y"C[_9O*^D[7UK9]Z!3;@T
M.0BWX )%##* IZL8P.T3A2E*^L69'<G95V^J_M71P-^R?WSPU%D W(=K .Y=
M!>!^8Q$S /^3'P;0/H&SO5)EJO")U1 L[/LQ'%<T-7\6#2;.BH8P0@2.BH2H
MTC4K80FUE"=DB)<ZH[P[)@PRE0ZK'9[<Y8)W;_,<'Q^^/WU]>O3A]$>1JA,U
M2C$K^6_,JQ DLF&"5.JNX$0"O:[%P;315@M*PO%P\@@I4Z-53CTI..QFVO7*
M  Q&$QSHZ8]89@>";[<ZUD_?$>SV\KC;IV4XON2_H@K.<@ZX87Y4^7W$1FKL
M>BW;EIT<DR.6/H>_70 <K"BDTH8($PP8CD#!"[SX_7#&K5X\^/W0X(%[)NQC
M,#M>34!$)0$!PAAN?"H8..\N&/]S/Q@7C?\$S@#,P(P'=Y<88SC$.1W<HRV&
M2S#NV^_TA5R]%&8D2B^8.O<@&E#X&*;\HE96#%(82-X3WL@GMJ0Y"\X(Z<4R
M>5:T7^\]_R!X[N8&W1]>"?XL.2GC<R&96@SL_CKF]D:<\(87NRIBU<^DRU8.
MXI=0ZEUE].Z>EK*TCAT+@23G\<[<:7;]C5BP0^0.TK5*.- TCA: <>5PQ0CL
MNL[I(P^*C",('G.AVXW=F/R>3^E6-[>H<X83,*NID8T_U41 *BT(,<G +>VH
MPR<QS].2$6$;S!2#T)0CG\???DSQ6BL4I+L)Z7RIB. -1,0H=&[A@X.3(46G
M-D5"48IV=0 ,6%'J/7JX<REGA".O9RI/RKS27WL6<F%"\BZ>V)X#^&W)J2.,
MM&-'O]*2W:$B0KD+VAMB_-]K3T"\K5X/0@=U[D Z&\EW6NW4W=A39^V?8:D*
MS"2%D-]EJ,LIY_#VI..B@7#IE:D=8Y]>&/L;J!@6MM*?J/&AY))[$?^,*,/3
MBY2F#T$0&@XX@CW1T8:"",^OZG),C<72FCG&^;BAQF%-A1W"] 4V$QO3<QJ^
M*0*9&$%ED8ZT<-3/.AL;0 OE+NHRA8EC"*G<D^/H,JVNY:WKFA9.V'E:9SKZ
MX^S,)F?2JS2+WG-]^U%,R[SW]/'#WHQOG^[U1%XN>9[DH(BII1_\X.>#GK>"
M&G]9PU:FI02=40RQ 05L=TS9P%7R8RK4>:>\CXY -6 7-(':OS3K@DK&_N@5
M3S).Q&\ZP1#2YL9KC9O)_N2-64327RCG##IUOZ#L0O1K \: ][J>ZN):'^[*
MAL@>:@9'J8H.L=[<\!'\E,\8<0=#V3G799%?@&+V%*S1(K"UU=!?.90VM"K#
MSYI\I%+41]ZE!GR'!1L@'75A&1J'<"4,PV]O:;R2Z,_PE/)R:.8DD#^K3B6!
M%BQXWI>BV@V04'HV\(=>$8J4>Z3+1&IVVW]?Q<C\I[_?#.@,A P/"9I#F2X\
M*:3G9)W"TN IZ1_[!##CC8H'A*&W[HG=-OTX</J\6X./FK)J%+97$ C&$2SQ
MRU 'P@KZNI;DWO:^Q-(C G'Q\@]T0B8+2YB60VVH/J(DU-C#$?46E^#ECEP=
MD[I.U@-XL*>0M7<XN:() Z*3>3"?_U16>#HC4DAO^YN0\$2F;:E,:LC1&K;0
M(?/)'5/?A5R>U;:G#%A:*1A4A/J3)*  )J4KKY-2;E/19?[9!O+6WF&3#1>F
M,FA GDYK[Z!=PUSE7FD7"A::HA5J+\/UB28JPQ!K \3D0:3$SUM<<YJ9NLXR
M&3RA#& 2+,4L)O2;O$XSR8QRPX9$C9TI1'>>&#P=63)Z)$!O&TQL]IE;R&32
MR3QDJB\M%EP]1962E0XW5M>JE(]D\U3PSFE52Y_XD@KDHASG I]Y5:2)4[W!
M<E2>I]"U#)40^9;:OH7L?KZ?URWEDF0)]@5W5FGA(QCBY3FEG=+!+R[NAN-+
M%%NY(K/>Y/PM2STW/S;@OUH+ZM:"1G':KBGLYE0%(4AK-&%('J[2LFZ<7OA$
MW7QCJT]IO8V>DM(\'[';ZRB]"T_N3N:[NZ\<%LHF/'INZI&?X<,$AOT\^D-E
M#7Z_TF3#U^&;FTWHV%5GT9$//OC;G+3X 38E[&JY9Y3N3WFBJLOGT;N+G2 1
M81;C>70^'L&@CTJP?N/GG)JD!7M3X"KL!=D+<Q5^,VU$!ZT1$5AN,K5H$HL_
M2([F6VQ%.C%():(W3!#(:6<P'Y43YC>=AUW'\PRST!U,,6E8--_0!R9+"$^+
M/GAVV8"U(AFN-0+R3 &T;;[2UUK:[(QM5%*J)?P^+.TJ(/LH?LQWH5-Q(0/K
M@$X_#XI*@5MT?7OL&6'#1#S3<-W==U@1HJ3%&?D$Y!^47LM[YM48ZF'?@5UA
MR;FD4W5=8 O0K9,A=:4L)VB:5!7H/PPQS!*:-+\JLBMC8>LK @W3C2_12XDI
M?I>X]E!4$&I.YW,$65*0D=R6G<V-LX$SC<SS.;H=O-Z<E[OIB,U V>;I'.HT
M1PM'R[F7=#B$I\.'&;?&QM:5'*( V^<OL"AB[?=>H"U*!B^]"]4<C= 'J6N,
MX;%EB\-("C@!Q8QTI3N!A9["Y02U=*XD4WKP%AS!KY(6];BUA2:GCY[%#3.]
M#F<V1)D7%+QH4@RKBKQXP4TDD! !H^V<*Y1@W.Q&@[1:I5AMP-6!UG>=HMHX
M@" #@KG!K4)># M*:19VUA@GM5K7 &%#=(XP")8&XUMB/\YOJ+7V[T:.#--'
MU.*$L:[BRWA)D9WH35'C!K1$'_Y&=O6$%)F)@J#YG@6RO_=.76GATHLF ZH]
M&@ )%58"9JE#+]N[5LBFB??9>[@0+4YKBW.QDZEH /V &P YB_:V65JEND&4
M.&\2U  8K]>1:\(R394AZ9%7)6'O4V"!E@L%^80R<-$!7X2,+JBW2A?4E0-M
MP%6&M#%MQA)#05X^#-0]!<\Q.#,% ![0"7FY(B\B1/<&!9XI;%^V]7";%\0>
MM2CGPYP.8Y>*\(L17)HA1M.??DAN'OB$KA8:IZ8_]@'I7LD295_:X_="Q!2N
M0.ZL1]YD5W[QC5F>8FX:EW^B_%9!N "BD/@$D;9"%#.IBE"&_!!C$&'DY2G*
MCZ#Y)*(6\@O9=509[H0+R6"1LQ^<'(7D"-L:&^,/@4ON!2[:O^V#:.@KW3J&
M\$H<(JPV':S@Q+>Z+K5">+P4-)R=Z!6W\:1>TY=R7-UT]B>+&_!<I4W%9Y?/
MI\1"*$WV1IC:=X6)+M'A15S?CK#-=9/C;T"^3#'7EI<\/WU[$F0DR0BD' 39
M<EF!9?,#%1+(C##.3VP+4CZON#":F:'PGI+HQD::_ LL!^9J2O]&K9P9[H<=
M0DOS_/N3:6NU6O0@X?8<$!5:Y,+!:/2F<3I2)E0CS%'21K!E]&'"NJ&<&,H@
MS2F^C"PDIV;LK)AWKZ3DNO(%KM+Z(YL+W-\8FZZJH:(T+NJV)-5>8H7R?GI
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MCQ%U*6,Q$!D)JV$NP$*#R\]R^Z2,7 B<Y6:66F5]I\>X-\"#B@OTPCDBL(@
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M^L5HFCM&C6"<"0 -(#BJ0@L-L5BNV];Z%TC:[1"P_S/7,TXO#-/T"D-69:_
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MET+P_H<PK;N;./7]4=M0@6%+5)K;;W3N](OL\E>^*ZCYIJ":'?\RL_U'#D'
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M+I%(9R6IWH= TAH%DC!&$N$M\#%*X3[FO,?EK1+*KM&M#/^7849O1,J8'AJ
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M(^/8T#6=CE5D9;YTZ*PLK0(<B[;_\!,(FT!UG3-CB*>;O8W"8&/4_GBCOC=
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M%#$F5RG*HY>.@^*N:4EFL-?CR\3X8"72Z)RB-]0.!*RG,1'<8(RQSI(QM^O
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M9SSGWKML/1G3I"_KU6TZ@(' =99]=W)$>$V&-7?;7F;F[2_#!Y"[-FTG-4C
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MXX4V8%_/L4?K78X922.@D*ZD L2L3HAA7.J4 V*+.(SLV+0#T_P=]\>$_P"
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M,C Q.3$P,C,N>'-D4$L! A0#%     @ +CQ83^IW3&3]"@  WX<  !4
M         ( !<P,  &ED>'@M,C Q.3$P,C-?;&%B+GAM;%!+ 0(4 Q0    (
M "X\6$^.D@J[5 <  "Y9   5              "  :,.  !I9'AX+3(P,3DQ
M,#(S7W!R92YX;6Q02P$"% ,4    "  N/%A/V&7G)6T.  "3#P  %P
M        @ $J%@  =&TQ.3(P-S@U+3%?.&MI;6<P,2YJ<&=02P$"% ,4
M"  N/%A/;[BH==LA  #,U@  $0              @ ',)   =&TQ.3(P-S@U
M,5\X:RYH=&U02P$"% ,4    "  N/%A/[2P!;0]2  !DU@$ %0
M    @ '61@  =&TQ.3(P-S@U,5]E>#$P+3$N:'1M4$L! A0#%     @ +CQ8
M3\?,)]5I&0  <(,  !4              ( !&)D  '1M,3DR,#<X-3%?97@Q
M,"TR+FAT;5!+ 0(4 Q0    ( "X\6$_.4JK!L&T  .FC @ 5
M  "  ;2R  !T;3$Y,C W.#4Q7V5X,3 M,RYH=&U02P$"% ,4    "  N/%A/
M?RP#+_X/  #E-P  %0              @ &7( $ =&TQ.3(P-S@U,5]E>#DY
<+3$N:'1M4$L%!@     )  D 50(  ,@P 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6616521776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Oct. 23, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct. 23,  2019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-19271<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">IDEXX LABORATORIES INC /DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000874716<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">01-0393723<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One IDEXX Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Westbrook<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">ME<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">04092<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">207<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">556.0300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, $0.10 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IDXX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>21
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm19207851_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "tm19207851_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "idxx-20191023_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "idxx-20191023_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "idxx-20191023.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 97,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "idxx",
   "nsuri": "http://idexx.com/20191023",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm19207851_8k.htm",
      "contextRef": "From2019-10-22to2019-10-23",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://idexx.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm19207851_8k.htm",
      "contextRef": "From2019-10-22to2019-10-23",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The start date of the period covered in the document, in CCYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://idexx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r11": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r13": {
   "Name": "Forms 10-K, 20-F, 40-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d-1"
  },
  "r14": {
   "Name": "Forms 20-F, 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220 and 240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-13"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>23
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M]8??5=CUQN[M/S:^",H6?MV%_ )02P,$%     @ +CQ83YE<G",0!@  G"<
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M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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M556_2O&BTVH0!>;_T'+,,S_Y U!+ P04    "  N/%A/NJ$YBM<!   R!@
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MY];0\$'B<UCQ',SI;G\*+TWRL&6=-XJ<[O9GJ,6@WLX%][]$\0-02P,$%
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M2P$"% ,4    "  N/%A/)^B'#H(   "Q    $               @ 'I
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( "X\6$^%'[CZ[P   "L"   1
M              "  9D!  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M "X\6$^97)PC$ 8  )PG   3              "  ;<"  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ +CQ83QOKH)>; @  DPL  !@
M     ( !^ @  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M "X\6$\@\H U50(  .P%   4              "  <D+  !X;"]S:&%R9613
M=')I;F=S+GAM;%!+ 0(4 Q0    ( "X\6$^ZH3F*UP$  #(&   -
M      "  5 .  !X;"]S='EL97,N>&UL4$L! A0#%     @ +CQ83S #][XW
M 0  (@(   \              ( !4A   'AL+W=O<FMB;V]K+GAM;%!+ 0(4
M Q0    ( "X\6$__P"8(O0   (4"   :              "  ;81  !X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( "X\6$\+C]@#(0$
M %<$   3              "  :L2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%
3!@     *  H @ (  /T3      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
